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SUMMARY 
This thesis describes a series of studies involving healthy subjects, carefully selected 
patients with functional movement disorders and organic movement disorders, in 
which different aspect of the mechanism underlying functional movement 
disorders were explored: 
1. The presence of physical precipitating factors at onset of functional 
movement disorder by using semistructured interviews. I found that most 
patients with functional movement disorder have a clear physical event 
prior to the onset of functional symptoms. 
2. The presence of a “jumping to conclusions” reasoning style that may 
predispose patients with functional movement disorder to accept new 
hypothesis on the basis of less evidence. They requested less evidence that 
healthy controls to make a judgement, which is here suggested to influence 
the manner in which they process novel sensory data occurring during 
triggering events.  
3. The role of attention in symptoms production by using different motor tasks 
in which the predictability of movements as well as the effect of explicit and 
implicit strategies in motor control were manipulated. Motor impairment in 
patients with functional movement disorder was found to be related to the 
employment of explicit strategies or when pre-planning movements is 
possible. 
4. The intensity and duration of tremor in patients with functional tremor in a 
real life situation using accelerometers. They were found to fail to perceive 
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that tremor is not present most of the time compared with patients with 
organic tremor. 
5. Finally, I explored the phenomenon of the sensory attenuation using a force-
matching task as a measure of sense of agency for movement in these 
patients. Patients with functional movement disorders have an abnormal 
sensory attenuation for movement, which may help to explain the lack of 
agency for the abnormal movement.   
These results contribute to the understanding of the mechanisms underlying 
functional movement disorders and by extension, other functional neurological 
symptoms, and demonstrate that they are amenable to neuroscientific study. 
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THESIS OVERVIEW 
A personal view 
Before coming to London, I completed my training in Neurology in one of the 
biggest hospitals in Barcelona, Spain, between 2004 and 2009. During that time, I 
dealt with the diagnosis and management of most acute and chronic neurological 
diseases. However, my experience with patients suffering from functional 
neurological symptoms was limited, not because they were not seen in the 
emergency department or in the outpatient’s clinics, but because most patients 
were lost to follow up. They usually were managed by explaining that they should 
not be worried about the symptoms because all tests had come back normal, that 
they must be anxious and depressed, and that this was the likely cause of their 
symptoms. I could feel how disappointed most patients were with this explanation 
and when they were told that they were discharged from the clinic to be referred to 
the Psychiatry Department. Most patients said that they actually did not feel 
depressed or anxious, that their symptoms were indeed very disabling and they 
could not see how their symptoms were going to improve. I could also see how 
uncomfortable the situation was for clinicians who were not confident in making a 
diagnosis and explaining the problem to the patient in a positive/explicit way. Also, 
I could perceive how the assumption of malingering was always (in an implicit 
manner) present in the discussion.  
The truth is that I was struck by how young and disabled many patients were and 
how little we could offer. Having said that, I would have never expected to do my 
PhD in functional neurological symptoms. I definitely preferred patients for whose 
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disorders there was no speculation or explanations that touched the barrier with 
philosophy.  
This impression has notably changed over the last 4 years. A more neuroscientific 
approach to them has shown me how complicated and fascinating clinical problem 
functional movement disorders are. The more I read, the more I realised that they 
represent an enigmatic area of medicine that has always existed but has always 
been considered the “ugly duckling” of neurology. I think the fear to face these 
conditions by most clinicians has resulted in a lack of improvement in terms of 
understanding of pathophysiology and treatment despite all the advances that have 
occurred in Medicine over the past decades. This fear displayed by neurologists to 
face functional neurological symptoms is in my opinion more than reasonable as no 
one teaches you during your career how to manage these patients. 
During these 4 years I have learnt the importance of making the diagnosis in a 
positive fashion rather than as a diagnosis of exclusion. In this regards, patients 
with functional motor symptoms are ideal because in contrast to patients with 
symptoms such as sensory loss, pain, fatigue and memory disturbance, these 
patients have objective signs on examination that are amenable to clinical and 
experimental measurement. This provides a degree of certainty about the diagnosis 
which may not be achievable in those whose symptoms are only measurable via 
self-report.  
I have also learnt that once one explains how the diagnosis has been reached, and it 
is put in context, that patients are open to treatment and may improve with no 
additional measures. Hostile patients turn out to be pleasant patients that look 
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forward to collaborating in research to better understand their condition. I have 
learnt that the brain is more fascinating than I ever thought it was during my 
neurology training.  
I have been amazed how despite all the normal investigations, these patients can 
inform you about different aspect of motor physiology and about other typical 
neurological diseases.  
From the academic point of view, there is still active debate about what to call this 
group of patients. In this thesis I have used the term “functional” and this is not 
something new. In the past, other authors including Yealland in Queen Square 
(Linden et al., 2013) preferred this term when treating soldiers with functional 
symptoms. “Hysteria” implies a pejorative meaning and it is not commonly used 
nowadays. “Non-organic” denotes what one does not have and may infer that the 
symptoms are imagined or not real. “Medically unexplained” is commonly used in 
medical circles but when a patient receives this diagnosis they also receive a label 
of uncertainty: “if my problem cannot be explained, is the doctor missing a rare 
disease?” In the title of this thesis I have included the term “psychogenic” in 
parenthesis because it is the most widespread term in the movement disorder 
community. However, this term implies that the aetiology of the symptoms is 
purely psychological. This one-dimensional approach is criticised in this thesis and 
therefore I considered somehow inappropriate to hold this label through the text. 
“Functional” does not imply aetiology and is not associated with negative 
connotations (Stone et al., 2002). However, it may be considered to be vague as in 
the past other conditions such as migraine or epilepsy were labelled as functional 
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because of the lack of structural abnormalities in the central nervous system. 
Nevertheless, given the current level of understanding of the underlying 
pathophysiology, I have considered that the term “functional” is the one that 
comes closest to my understanding of these perplexing symptoms.  
On the other hand, it may sound inconsistent that I have sometime used the term 
“organic” to designate more typical neurological diseases but not by this I dismiss 
the possibility that functional symptoms have a neurobiological basis. 
Approval was obtained from the National Hospital for Neurology and 
Neurosurgery/Institute of Neurology (NHNN/ION) Joint Ethics Committee for all the 
studies included in this thesis and all participants provided written consent to 
participate according to the Declaration of Helsinki. I have included the 
methodology and the results of each of my studies in a different chapter, with the 
hope of simplifying the reading of this thesis. 
Chapter 1 is a general introduction to functional movement disorders. This chapter 
covers the current state of knowledge regarding phenomenology, diagnosis and 
management of this group of patients.  
Chapter 2 is a review of previous literature on the pathophysiology of functional 
symptoms in general. It covers information from ancient Egypt to the beginning of 
the 20th century but with special focus on the 19th century and three of the most 
important authors in this period: Charcot, Janet and Freud. Particular attention is 
paid to functional movement disorders, when mentioned in their writings.  
Chapter 3 describes the specific aims and hypothesis of this thesis. 
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Chapter 4 describes the methodology and results of a clinical study designed to 
assess the presence of physical precipitating factors at the onset of functional 
movement disorders. Psychological factors prior to the development of functional 
symptoms have been classically highlighted in the past but potential physical 
triggers to these symptoms have been mostly neglected. In this study, semi-
structured interviews were used to retrospectively identify physical events that 
occurred closely related to the onset of functional movement disorders.     
Chapter 5 describes the methodology and results of an experiment assessing the 
presence of a cognitive bias known as “Jumping to Conclusions” in patients with 
functional movement disorders. Patients who display this bias are more prone to 
accept new hypothesis on the basis of limited evidence compare to healthy controls 
and this might be hypothesised to favour the development of functional symptoms 
along with other factors.  
Chapter 6 describes the methodology and results of two experiments designed to 
assess the effect of explicit strategies and predictability of events on motor control 
in patients with functional movement disorders. Clinically attention is known to 
play an important role in symptoms generation and these experiments are an 
attempt to study this aspect in experimental conditions.  
Chapter 7 describes the methodology and results of a study the assessing duration 
and intensity of functional tremor in real life conditions compared to patients with 
other types of tremor. For that, a wrist-watch actigraph that had been previously 
demonstrated to optimally capture tremor was used for five consecutive days. 
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Results were compared with the patient’s subjective experience of tremor recorded 
in a diary. 
Chapter 8 describes the methodology and results of an experiment assessing the 
phenomenon of sensory attenuation that has been previously proposed to be an 
implicit measure of agency for movement. Patients with functional movement 
disorders report their abnormal movement to be involuntary and it is believed that 
most of them are not feigning. We sourced for an abnormality in the sensory 
attenuation phenomena to help and explain the lack of agency for movement in 
this group of patients.  
Chapter 9 contains a description of more modern models about the 
pathophysiology of functional symptoms (especially functional movement 
disorders), a more unified discussion of the results presented in this thesis, and an 
attempt to integrate them within a contemporary theory of brain function. 
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Chapter 1: General introduction to functional 
movement disorders 
Part of the information presented in this chapter was originally published in the form of a 
book chapter: Pareés I, Edwards MJ. Psychogenic Movement Disorders. Ed Wolters & 
Baumman. VU University Press, 2014. Page 675-690.  
1.1 Definition 
Functional movement disorders (FMD) are part of the broad spectrum of functional 
neurological symptoms, which together account for 16% of new patients attending 
neurology outpatients’ clinics (Stone et al., 2010). Patients can present with the 
whole range of abnormal movements, which by definition are incongruous and 
inconsistent with movement disorders that occur in typical neurological diseases. 
The different terms used along the history to describe these patients (functional, 
hysteria, psychogenic, psychosomatic, conversion disorder, somatisation disorder, 
non-organic, medically unexplained) reflects the lack of understanding of the 
mechanisms that contribute to FMD.  
1.2 Epidemiology 
The prevalence of FMD is uncertain due to the lack of consensus on diagnostic 
criteria and different methodologies used to ascertain cases. It has been estimated 
between 1% and 9% in general neurological clinics (Marsden, 1986, Lempert et al., 
1990, Factor et al., 1995). In adult movement disorders clinic this ranges between 2 
and 20% (Hallett, 2006). The mean age at onset is between 37 and 50 years and 
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usually, women are more commonly affected (Hinson et al., 2005). In 
approximately 70% of the cases, patients present with tremor or dystonia. Although 
FMD usually occur as a single neurological diagnosis, they have been reported to be 
associated with “organic” neurological disorders in 10-15% of the patients 
(Ranawaya et al., 1990, Stone et al., 2012). This assciation has been called 
“functional overlay” and has been the topic of recent studies (Onofrj et al., 2010, 
Onofrj et al., 2011, Stone et al., 2012, Pareés et al., 2013). FMD are thought to be 
uncommon in the elderly. However, one study has reported that 21% of a large 
cohort of patients with FMD had an onset of the symptoms after the age of 60 
years, which highlights the importance of symptoms recognition in this group of age 
(Batla et al., 2013). Children can also develop FMD, with gait disorder and tremor 
the most commonly seen (Schwingenschuh et al., 2008). In a series of children with 
FMD reported by Schwingenschuh et al the average age at onset was 12.3 years, 
with a clear predominance of females among the patients (80 %) (Schwingenschuh 
et al., 2008).  
1.3 Clinical Presentation 
1.3.1 General clues 
Different features from the clinical history and examination findings are commonly 
noted in patients with FMD irrespective of the type of movement disorder that the 
patient displays and, although none of these features is entirely specific for FMD 
and diagnosis should not be based on these features alone, they can be helpful as 
part of the diagnostic process. 
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FMD often have a sudden onset with rapid progression to maximum severity, they 
can present spontaneous remissions, paroxysmal exacerbations, and relapses. 
Patients may experience a shift in phenomenology over time (tremor turning to 
abnormal posture for example), and may have a history of previous functional 
medical symptoms.   
General clues on clinical examination include the co-existence of other functional 
signs such as “give-way” weakness, positive Hoover’s sign, non-physiological 
patterns of sensory loss on clinical examination such as midline splitting of sensory 
loss or altered vibration across frontal bone. It has recently highlighted the frequent 
presence of convergence spasm during the examination of patients with FMD 
(Fekete et al., 2012).  
1.3.2 Functional tremor 
Functional tremor (FT) is the most common form of FMD (Factor et al., 1995, 
Hinson and Haren, 2006).  A combination of rest, postural and intention tremor is 
commonly seen, which is an unusual pattern for organic tremor. Arms are the most 
common body part affected, usually sparing the fingers. Tremor of other body 
parts, including legs, head or palate, can also be seen. The onset of the tremor is 
abrupt in a large number of patients, often following a physical injury (Jankovic et 
al., 2006). 
Distracting the patient’s attention away from the tremor during examination 
usually makes FT significantly change in frequency or even stop it. A range of 
distraction tasks have been assessed including cognitive distracters (serial 
subtraction), tapping with an unaffected limb at a different frequency to the tremor 
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and making a sudden ballistic movement with the other hand. With clinical 
assessment alone (without supplementation with tremor recordings), tapping tasks 
are most sensitive and specific for distinguishing essential tremor from FT. Self-
paced cognitive tasks are not very effective. Also, tapping with the hands may not 
be a good distractor for tremors affecting legs, head or tongue. In these cases, 
tapping with one foot or moving the tongue side to side respectively can be of help.  
Using tremor recordings, tapping tasks have again been shown to be helpful in 
distinguishing FT from organic tremors. Patients with FT may “entrain” to the 
tapping frequency, may show a shift in tremor frequency towards the tapping 
frequency, or may instead be inexplicably unable to perform the tapping task 
correctly with their normal hand. This illustrates an important point with distractor 
tasks which is that performance of the task must be adequate to draw attention 
away from the tremoring limb. This is likely why self-paced tasks (whether cognitive 
or motor) are not good at discriminating patients with FT from organic tremor 
(Roper et al., 2013). Ballistic movements of the non-tremoring limb cause a small 
pause in the tremor in patients with FT. Additional electrophysiological 
characteristics include a paradoxical worsening of the tremor with loading (which 
typically damps organic tremor), and co-contraction at the onset of tremor. 
Recently these tests have been compared head-to-head in a group of patients with 
FT and a mixed group of patients with organic tremors (Parkinson’s disease (PD), 
dystonic tremor, essential tremor, neuropathic tremor)(Schwingenschuh et al., 
2011). No single test was found to be of sufficient sensitivity and specificity to 
distinguish FT from organic tremor. However, a cut-off score was devised by 
combining several of these measures and FT could be successfully distinguished 
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from “organic” tremor. Nevertheless, these preliminary results are awaiting 
confirmation in a prospective study. 
1.3.3 Functional dystonia 
Functional dystonia is the second most common FMD after tremor (Factor et al., 
1995). Patients with functional dystonia are usually women who present with fixed 
abnormal postures typically triggered by apparently minor injury, accompanied by 
severe pain similar to that noted in chronic regional pain syndrome type 1. Nature 
of fixed dystonia is under debate and concerns about whether it should be 
classified as a FMD or as a form of “organic” movement disorder still exists. 
Recently, it has been proposed that abnormalities in central body schema may be 
present in these patients, which might contribute to pain and other unusual 
features, such as the seeking of limb amputation seen in this condition (Edwards et 
al., 2011).  
Clinically, functional dystonia affects predominantly the limbs, and rarely the 
neck/shoulder region or jaw (Schrag et al., 2004). Functional blepharospasm has 
been recently reported, which displays different electrophysiological features 
compared with typical blepharospasm (Schwingenschuh et al., 2011). An unusual 
distribution of dystonia given the age of onset can be a further clue that points 
toward functional dystonia. Primary dystonia has a very typical anatomical 
distribution which depends on age of onset: generalized (with classic limb onset) in 
individuals younger than 25 years, focal involving upper limb in individuals between 
25-45 years and focal involving craniocervical area in individuals of more than 45-50 
years. Importantly, unusual distribution given the age of onset age can also be a 
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clue for secondary/neurodegenerative dystonia and these should be ruled out. In 
functional dystonia there is typically an absence of task/position specificity 
commonly seen in “organic” dystonia and patients often do not have sensory tricks. 
Some patients do develop limb contractures demonstrating maintenance of 
postures even when unobserved. It can be difficult to demonstrate distractibility in 
fixed dystonia. This difficulty may occur because fixed dystonia maintenance of 
postures does not need a similar level of attention as maintenance of tremor. 
However, a brief give way of muscle activity in the affected limb can be felt with 
distraction in a number of patients.  
It has been recently reported that some patients with fixed dystonia can respond 
immediately (within minutes) to the botulinum toxin injections (Edwards et al., 
2011). This is in contrast to the known physiological effects of botulinum toxin 
which usually take 36-72 hours to begin to become apparent. The dramatic 
response seen in these patients is therefore likely to be due to placebo effect and 
may help to confirm that such patients are different from those with typical 
dystonia.  
1.3.4 Functional myoclonus 
Functional myoclonus is reported in about 20% of patients with FMD (Factor et al., 
1995). Functional myoclonus can be difficult to differentiate from typical myoclonus 
as it is difficult to demonstrate distractibility in patients with intermittent 
movements. Electrophysiological tests can be particularly helpful in supporting the 
clinical diagnosis.  Simple recording of the duration of the jerks can be of benefit, 
particularly to demonstrate variability in duration and recruitment pattern of 
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electromyography (EMG) burst, suggestive of a functional cause. Bursts of less than 
75ms in duration are unlikely to be functional. However, bursts of more than 75ms 
do not prove myoclonus to be functional as some forms of “organic” myoclonus 
(e.g. brainstem myoclonus, spinal segmental myoclonus) may have EMG burst 
lengths longer than 75ms. The most definitive test to confirm the functional origin 
of the myoclonus is detection of the readiness potential or Bereitschaftspotential 
(BP). This electroencephalography (EEG) potential starts around 1.5s before 
voluntary self-paced movement, and reflects activity in areas associated with 
movement preparation (Shibasaki and Hallett, 2006).  It can be found in patients 
with functional myoclonus, but has never been reported in patients with typical 
myoclonus. Three studies assessing the presence of BP have confirmed that most 
patients carrying a diagnosis of idiopathic spinal myoclonus or propriospinal 
myoclonus were in fact of functional origin (Esposito et al., 2009, van der Salm et 
al., 2010, Erro et al., 2013). 
1.3.5 Functional gait disorder 
Abnormal gait can be an isolated phenomenon in patients with FMD or mixed with 
other clinical manifestations. In the classical manifestation of functional gait 
disturbance, patients veer from side to side when walking, often waving the arms at 
the same time. They seem to be about to lose their balance, but tend not to. This 
ability to shift their centre of gravity from one side to the other without losing 
balance is actually a demonstration of good balance in direct opposition to the 
patient’s subjective report of poor balance. This pattern has been termed the 
“walking on ice” gait. Other features include: narrow base, hesitation, dramatic 
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response to Romberg’s test and tests of postural stability, “uneconomic” postures 
or excessive slowness.  Some patients with typical neurological conditions such as 
Huntington’s disease or generalised dystonia can exhibit bizarre patterns of gait and 
clinical experience in both functional and “organic” disorders can be required to 
make a clear diagnosis.  
1.3.6 Functional parkinsonism 
Functional parkinsonism is relatively rare, accounting for the 10% of cases of FMD 
(Hallett, 2011). The diagnosis is not always easy and a detailed clinical history and 
physical examination looking for positive clinical signs of FMD is required. All 
features of parkinsonism can be present. In a series of 9 patients, 7 had a 
predominant tremor form and only two had akinetic-rigid form (Benaderette et al., 
2006). This indicates that in fact “true” functional parkinsonism, rather than people 
who have functional rest tremor, is probably very rare. In such patients, rigidity may 
be present but feels similar to voluntary oppositional resistance against passive 
movements rather than true cogwheel rigidity. Movements may appear to be very 
effortful and slow, but true bradykinesia with decrementing amplitude with rapid 
repetitive movements is not seen. When patients are distracted, velocity of the 
movements can normalize. Postural stability testing may lead to dramatic loss of 
balance and falls. Speech often becomes stuttering, “baby-like” or develops a 
foreign accent. The handwriting is laboured and irregular but without typical 
micrographia (Jankovic, 2011). It is important to recognise that placebo response 
can be quite sizeable in patients with PD where it is associated with dopamine 
release (de la Fuente-Fernandez et al., 2001), so caution needs to be taken in 
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interpreting response to placebo in patients with suspected functional 
parkinsonism. Dopamine transporter (DaT) single-photon emission computed 
tomography (SPECT) scanning is a useful test to investigate the integrity of the 
nigrostriatal system and discriminate functional parkinsonism from PD. This test will 
be abnormal in patients with PD and normal in functional parkinsonism. It is 
important to emphasize that normal DaT scans are seen in patients with “organic” 
post-synaptic causes for parkinsonism such as drug-induced parkinsonism. Also, it is 
worth to note that the diagnosis of PD does not exclude the presence of functional 
symptoms or the reverse. Indeed, it has been suggested that patients with PD are 
more prone to develop functional symptoms than other neurodegenerative 
disorders (Onofrj et al., 2010, Onofrj et al., 2011).  
1.3.7 Other functional movement disorders: chorea, tics and 
paroxysmal movement disorders 
Functional chorea is distinctly rare. So far, only two patients have been reported, 
one of them with a family history of Huntington’s disease (Fekete and Jankovic, 
2010). Here, clues for the diagnosis were normal saccadic eye movements, lack of 
motor impersistence and marked decrease of chorea when patient was distracted 
during performance of voluntary repetitive movements. 
Functional tics are also rarely described. Surprisingly, in a series of patients with tics 
reported by Mejia and Jankovic, 16 out of 155 patients with tics (10.3%) were 
considered to have functional tics (Mejia and Jankovic, 2005). The rather high 
frequency of functional tics this sample was subsequently questioned, arguing that 
the criteria used to give the diagnosis of FMD in these patients was not specified 
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and that typical indicators of FMD such as abrupt onset, response to placebo or 
suggestion or increase with attention and cessation with distraction may not help 
differentiate “organic” from functional tics as “organic” tics may begin also 
abruptly, be under some voluntary control and intensity can vary with attention. 
This highlighted the need of well-defined criteria to characterize functional tics. 
A ‘‘paroxysmal’’ component is one of the most important clinical presentations of 
FMD. However, functional paroxysmal disorders have been rarely mentioned in the 
literature. Because “organic” paroxysmal disorders such as paroxysmal kinesogenic 
dyskinesia, paroxysmal non kinesogenic dyskinesia and paroxysmal exercise 
induced dyskinesia or even focal seizures are by definition brief and reversible the 
clinical diagnosis can be very difficult. “Organic” counterparts have, however, 
typical precipitating factors and the length of the attacks is also well defined for 
each type and incongruous features with them can therefore be suspicions of a 
paroxysmal FMD (Ganos et al., 2014). Often, EEG and video-recording of the attack 
are essential to reach the diagnosis.  
1.4 Diagnosis 
Over the past years, marked emphasis amongst movement disorder specialists has 
been placed on using positive physical signs and investigation findings to support 
the diagnosis of FMD, rather than making a diagnosis of exclusion or based on the 
presence of psychological distress.  
The most widely used criteria were developed by Fahn and Williams in 1989 (see 
Box 1) (Fahn and Williams, 1988). FMD are divided into four categories of diagnostic 
certainty: documented, clinically established, probable and possible. These criteria 
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were in fact first developed for functional dystonia alone, but were later expanded 
to cover all FMD. 
Gupta and Lang have suggested revisions to these criteria which delete the 
“possible” category as being not sufficiently specific for FMD, and also seek to 
introduce the concept of a laboratory supported level of certainty (Gupta and Lang, 
2009). Shill and Gerber proposed alternative criteria, but these have been criticised 
for relying too heavily on historical factors such as “disease modelling” without 
reference to the movement disorder phenomenology (Shill and Gerber, 2006). 
Recently, these criteria have been assessed with regard to inter-rater reliability, and 
have been found to demonstrate moderate to poor reliability for the probable and 
possible categories (Shill and Gerber, 2006). Therefore new criteria, which perhaps 
include more specific direction as to the positive physical signs that predict FMD 
rather than the unspecified “incongruency” with typical movement disorders, is 
urgently needed to improve reliability. 
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Box 1. Fahn and Williams criteria for functional movement disorders 
1. Documented 
Persistent relief by psychotherapy, suggestion or placebo has been 
demonstrated, which may be helped by physiotherapy, or the 
patient was seen without the movement disorder when believing 
him- or herself unobserved 
2. Clinically established 
The movement disorder is incongruent/inconsistent with typical 
movement disorder plus at least one of the following three:  
 Other psychogenic signs 
 Multiple somatisations 
 Obvious psychiatric disturbance 
3. Probable 
The movement disorder is incongruent/inconsistent with typical 
movement disorder 
The movement disorder is incongruent/inconsistent and there are  
psychogenic signs 
The movement disorder is incongruent/inconsistent and there are 
multiple somatisations 
4. Possible 
The movement disorder is incongruent/inconsistent and there is 
evidence of an emotional disturbance 
 
Giving the diagnosis of a FMD to patients can be sometimes even more challenging 
than making the diagnosis itself. A poor explanation such as “all the tests have 
come normal, therefore you are stressed” often causes incredulity and sometimes 
hostility (mainly because many patients do not consider psychological factors being 
relevant in their cases and the explanation is therefore no convincing). However, a 
successful explanation of the diagnosis can be therapeutic itself. Explaining what 
they do have, what they do not have and why (for example PD), how you have 
reached the diagnosis (for example explaining the positive signs in the 
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examination), stating that the diagnosis is very common and that you believe them 
(you do not think that it is all in their minds or they are putting the symptoms on) 
are often of help (Stone et al., 2013). It is also important to explain that a potential 
for reversibility does exist and that treating psychological issues (when relevant) 
can also help to treat the condition.  
1.5 Differential diagnosis 
Many clinicians do not feel confident during the diagnostic process and the worry of 
erroneously labelling a patient as functional is not uncommon. A systematic review 
of studies of misdiagnosis however found that only 5% of patients had the wrong 
diagnosis after an average of five years (Stone et al., 2005). This rate is similar to 
those found for most neurological and psychiatric conditions. However, the 
diagnosis is not always easy and it is usually prudent to ask a specialist to confirm 
whether it is correct.  
I have detailed general clues in the history and positive signs in the examination for 
each type of FMD that may help to differentiate them from their “organic” 
counterparts. Additionally, it have recently discussed general pitfalls in approaching 
patients with functional symptoms (those that can lead erroneously to diagnosis 
neurological disease as functional were called “mimics” and those that can lead to 
diagnosis of functional symptoms in patients that have a typical neurological 
disease were called “chamaleons”) (Stone et al., 2013). Putting too much emphasis 
in the presence of psychiatric disorders and life events, failure to consider that 
many patients may have an overlay of functional symptoms and typical neurological 
diseases, normal imaging or the presence of “la belle indifference” can lead to 
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misdiagnose patients as functional. Among the chameleon, to rely on the opinion 
that a patient is “nice, normal, or not stressed” to be functional as well as the fact 
that symptoms can come after injury or a minor disease or that the patient is too 
old can be misleading. Finally, assuming that normal neuroimaging exclude 
neurological diseases or in contrast, assuming that all structural abnormalities are 
relevant may also result in a misdiagnosis in both directions (Stone et al., 2013).  
Because FMD resemble movement that are voluntarily produced, one can always 
argue that patients are deliberately assuming symptoms in order to gain benefits. It 
is generally acknowledged to be very difficult to distinguish malingering from “true” 
FMD, but the consensus of opinion is that malingering is likely to be rare and is not 
a satisfying explanation for the disorder in the majority of patients (van Beilen et 
al., 2009, Hallett, 2010). Data arguing against the idea that malingering is the most 
likely explanation for FMD comes from functional imaging studies in FT and fixed 
dystonia (Voon et al., 2010, Schrag et al., 2013). Here, patterns of brain activation in 
patients were different to those seen in subject feigning symptoms.  
1.6 Treatment 
There are no official guidelines for the treatment of FMD. However, an effective 
communication of the diagnosis that allows patients to understand their symptoms 
seems a good start. The benefit of simply explaining the diagnosis, at least in the 
early stages, has been found to lead to long-term resolution of symptoms in overall 
functional symptoms (Hall-Patch et al., 2010).  
Referral of patients with FMD to physiotherapy services is common practice by 
neurologists. However, in a recent survey most physiotherapists reported that 
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although they have interest for this group of patients, they have a low self-judged 
knowledge about how to treat them. Preliminary evidence for regular low-medium 
intensity walking exercise has been found in a single-blind study which assessed 
patients with FMD after a 12 week program (Dallocchio et al., 2010). In a study of 
60 patients from the Mayo clinic with functional motor symptoms, a 5 day inpatient 
physical rehabilitation program produced benefits in over 60% of patients which 
were sustained in most for over 2 years (Czarnecki et al., 2012). This encourages the 
development of further studies to provide evidence for how physiotherapy services 
could best be structured to design and deliver successful treatments to patients 
with FMD. 
Psychological intervention can be helpful in patients who consider psychological 
factors as relevant in symptom development or maintenance. Indeed, a small study 
provided preliminary evidence for a positive effect of antidepressant treatment in 
those patients diagnosed with primary conversion disorder but not in those with 
somatisation disorder (Voon and Lang, 2005). In patients with clear psychological 
stressors but who are reluctant to try this strategy, explaining that cognitive 
techniques are commonly used in medicine to help to control physical symptoms 
(e.g. modern management of chronic pain) may encourage them to try this 
approach. Recently, a community- based study of functional neurological symptoms 
demonstrated that patients receiving cognitive behavioural therapy (CBT)-based 
guided and usual care had more benefit than those who received usual care alone 
(Sharpe et al., 2011). 
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The use of placebo as treatment strategy for FMD is still under debate. Because 
prognosis and successful treatment of FMD may be highly dependent on the 
patients’ belief that they will get better, some neurologists support the use of 
placebo in this group of patients. Indeed, dramatic therapeutic benefits mediated 
through placebo therapy have been described (Edwards et al., 2011). However, loss 
of patient autonomy and the erosion of doctor-patient relationship are important 
ethical concerns that should be taken into account. Recently, the need for clinical 
trials to define optimal regimes for placebo therapy in these patients as well as for 
health professional education in the use of placebos has been stressed 
(Rommelfanger, 2013).  
Additional treatments have been suggested to be effective in FMD but evidence is 
poor. For example, intrathecal baclofen was reported to be effective in fixed 
dystonia compare to placebo (van Hilten et al., 2000). However, placebo control 
was only used for the initial test dose of intrathecal baclofen, and it is not known 
whether there was systematic unblinding of the participant by systematic effects of 
the baclofen. Low frequency repetitive Transcranial Magnetic Stimulation (TMS) has 
been used as a therapeutical tool in FMD with some promising results (long-lasting 
clinical improvement immediately after TMS session was seen in many patients) 
(Dafotakis et al., 2011, Garcin et al., 2013).  However, the unmasked nature of the 
intervention in most of these studies makes placebo effect a likely explanation for 
the results. 
There is limited controlled trial data to guide treatment in FMD but the evidence 
that is available suggests that a multidisciplinary approach gives the best chance of 
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benefit.  A recent study that retrospectively evaluated a multidisciplinary inpatient 
programme suggested this approach can provide long-lasting benefit for some 
patients with treatment-refractory FMD, at least as measured by retrospective self-
report (Saifee et al., 2012). However, similar to other studies, most patients failed 
to return to work and cessation of health-related financial benefits was 
uncommonly seen despite of reporting clinical benefits. 
1.7 Prognosis 
Data on long-term prognosis are scarce, but most studies point to significant impact 
in quality of life. For example, one study comparing patients with FMD and PD 
patients on different measures of disability and quality of life showed that patients 
with FMD reported levels of disability similar to those seen in PD (Anderson et al., 
2007). In a long-term follow up study, 90% of a group of 80 patients with a range of 
FMD still had abnormal movements after a mean of 3.2 years since their initial 
assessment (Feinstein et al., 2001). In other study, a third of patients were 
employed at the time of follow up, while 11.5% were on disability and 1.3% were 
involved in litigation (Thomas et al., 2006). 
More optimistic studies of long-term outcome in FMD have showed that half of the 
patients report an improvement in their symptoms at last follow up (3-5 years after 
presentation)(Jankovic et al., 2006). Factors that predicted a favorable outcome 
were a short duration of illness, patient's perception of effective treatment by the 
physician and the presence of a comorbid psychiatric diagnosis of depression or 
anxiety (which is therefore amenable to treatment) (Feinstein et al., 2001, Thomas 
et al., 2006). Negative outcome at long-term follow-up is associated with long 
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standing symptoms (more than 6 months) (Factor et al., 1995), insidious onset of 
movements and primary psychiatric disorder of hypochondriasis, factitious disorder 
or malingering (Voon and Lang, 2005).  
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Chapter 2: The pathophysiology of functional 
movement disorders – the historical view 
An historical review of any illness is always important. It is a very useful instrument 
to determine what happened in the past to an entity, and how previous 
contributions made an impact on the modern concept of a particular illness. It also 
often provides clues on future directions for research.  
In this regard, functional symptoms are complex as there is a broad spectrum of 
manifestation ranging from neurological symptoms such as sensory, motor, 
memory or visual disturbances to non-neurological manifestation such as 
gastrointestinal symptoms. Some authors have argued for a common theory 
accounting for all the symptoms (Brown, 2004) whereas others have suggested a 
specific mechanism for each one. The proneness of functional patients to develop 
more than one type of symptoms over the time supports, in my opinion, the view 
that there should be common underlying mechanisms.  
In this chapter I will review different theories that have been proposed to explain 
functional neurological symptoms. Here, I will use (in contrast with the rest of this 
thesis), the word “hysteria” to be consistent with the nomenclature used in the 
past. I have included information from ancient times (even though it is likely that 
the term hysteria at that time was also employed to describe other entities 
different from functional symptoms as defined in modern times). I have focused the 
research mostly on the 19th century and the beginning of the 20th century, a period 
in which hysteria was widely discussed and a theme of debate in the medical 
literature. I have concentrated on reading some of the original work of three 
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important authors who showed a vivid scientific interest in hysteria: Jean-Martin 
Charcot, Pierre Janet and Sigmund Freud. I present their main theories but I also 
highlight the specific accounts of FMD when they reported them. By doing this, I do 
not mean that these three authors are the only important ones. There are other 
relevant thinkers, who are not mentioned in this thesis, whose contributions were 
undoubtedly of value. My aim was, however, to read in depth and capture the most 
illustrative thoughts from that time.   
Janet once wrote that most theories have the inconvenience of being transitory, “of 
disappearing soon after us, but it would be a singular illusion to seek to do 
something eternal” (Janet, 1907). What follows demonstrates that in fact each 
theory does have in itself something eternal, something that is still undoubtedly 
influencing our current understanding of these common and disabling symptoms.  
2.1 Ancient Egypt, Greece and Rome 
It is thought that the first description of hysteria comes from the ancient Egyptians 
(Kahun Papyrus, 1900 BC) (Tasca et al., 2012). They described them as being due to 
spontaneous movements of the uterus in women’s body but symptoms had not yet 
been given a specific term. 
It was Hippocrates (5th century BC) who first used the term hysteria (Gilman, 1993). 
He suggested that the causes of the symptoms were poisonous humours which, 
due to an unsatisfactory sexual life, had never been expelled. He stated that 
because a women’s body was naturally cold and wet, they were predisposed to 
decomposition of the humours. As a prevention of the disease, the suggestion that 
even widows and unmarried women should get married and live a satisfactory 
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sexual life was made. Once women had acquired the disease, they were advised to 
treat themselves with acrid or fragrant fumigation of the face and genitals (Tasca et 
al., 2012). 
Although the theories on hysteria developed by one of the greatest physician of 
ancient Rome, Claudius Galen (2nd century AD), were analogous to those of 
Hippocrates, he was the first who emphasised  the difficulties that just one single 
organ such as the uterus, could cause several different symptoms. He wrote with 
reference to Hippocrates: “Ancient physicians and philosophers have called this 
disease hysteria from the name of the uterus, that organ given by nature to women 
so that they might conceive. I have examined many hysterical women, some 
stuporous, others with anxiety attacks [...]: the disease manifests itself with 
different symptoms, but always refers to the uterus” (Tasca et al., 2012).  
2.2 Middle Ages 
The Roman Empire fell but Greco-Roman medical culture survived thanks to, 
amongst others, the Persian Avicenna (980-1037) and the Andalusian Jew 
Maimonides (1135-1204). The theories of Hippocrates and Galen were conserved 
and hysterical symptoms were treated in a “scientific” way with the use of Melissa 
as a natural remedy (Tasca et al., 2012). 
From the 13th century onwards, the Inquisition played an important role in how 
manifestations of illnesses, especially those due to psychiatric conditions, were 
interpreted. If a physician was not able to identify the cause of a disease, likely to 
occur with functional symptoms, it was thought to be due to the presence of a 
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demon. Therefore, “hysterical” women were commonly exorcised (Tasca et al., 
2012). 
2.3 Modern Age 
During the 16th and 17th century the basis of modern medical science were 
established. The physician Thomas Willis (1621-1675) referred for the first time to 
hysteria as being related to the brain and to the nervous system (Tasca et al., 2012). 
While many of his contemporaries were looking for the causes of psychiatric 
disorders in other organs, such as the uterus, lungs and spleen, he used to dissect 
his own patients with the aim of relating the symptoms to brain pathology, 
including patients with hysteria (Eadie, 2003, Molnar, 2004). It is during this period 
that a door for a neurological explanation was opened and the suggestion that 
perhaps hysteria was not a condition exclusive to females and instead, could affect 
both sexes raised.   
2.4 19th and 20th Centuries 
In the 19th century, a burst of scientific interest to understand hysteria occurred and 
France became the epicentre of this study. Prominent physicians developed 
methods and treatments for hysterical symptoms which sometimes divided the 
medical community.  
2.4.1 Briquet 
His Treatise on Hysteria, published in 1859, contains clinical and epidemiologic 
details of 430 patients with hysteria seen over a decade. He described several 
etiological factors such as “affective” temperament, family history, low social class, 
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sexual immorality or poor physical health (Mai and Merskey, 1981). Paul Briquet 
regarded hysteria as a "Neurosis of the Brain" in which the causative agents can act 
on the "affective part of the brain" in a susceptible and predisposed individual 
(Hallett, 2006). In terms of treatment, Briquet emphasized the importance of an 
improvement in social circumstances and the need to minimize environmental 
problems. With Briquet the historic association of hysteria and disease of the uterus 
was finally discredited (Mai and Merskey, 1981). 
2.4.2 Charcot 
Jean-Martin Charcot (1825-1893) was a pioneer of modern neurology during the 31 
years of his working life. His contributions to medical knowledge were based on a 
systematic use of physiology and pathology accompanied by a rigorous clinical 
analysis.  By the time of his death, the nosology of the main neurological diseases 
had been carefully and methodologically classified. He tried to apply his 
methodology to understand also hysteric symptoms and it was him the one who 
treated, perhaps for the first time, hysteria as an issue worthy of serious study.  The 
Clinical Lectures on the Diseases of the Nervous System summarises all the lectures 
given by Charcot between 1882 and 1885 in the lecture theatre of the Salpetriere 
hospital in Paris (Charcot, 1889). Here, he focuses on the difficulties on diagnosing 
and treating patients with hysteria among other neurological diseases. He gives a 
detailed description of the phenomenology and care provided to patients admitted 
on the ward suffering from several functional symptoms such as “hystero-epilepsy”, 
“hysteric mutism”, “hysteric amyotrophic”, and “hysterical paralysis”. Several men 
are described and this was used by Charcot to demonstrate to his students that 
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hysteria could occur in men, though he reported the proportion previously 
suggested by Briquet of 1 man to 20 women was exaggerated (Charcot, 1889).  
In these lectures, Charcot also presents cases of FMD. He describes hysterical tics 
on the lower face in a 15 year-old girl and dedicates extensive work to what he 
called “hysterical contractures of traumatic origin” highlighting the common 
presence of physical injuries preceding the abnormal posture, a condition 
nowadays called fixed dystonia.  
In lecture III, he presented the case of a 34 year-old lady with a history of hystero-
epilepsy (she displayed in the past both epileptic seizures and non-epileptic 
attacks). During a period in which non epileptic attacks had completely 
disappeared, she had a work accident after tripping on the top of a staircase, falling 
heavily on her left side. Charcot stressed the fact that the injury was mild but the 
next morning she had a plantar flexion and inversion of the left foot, which in 
Charcot’s words “attempts to passive movements were useless” (Charcot, 1889).  
With this case, Charcot highlights several typical aspects of functional movement 
disorders such as the sudden onset of the abnormal movements, that physical 
triggers are common, that the abnormal movements reach their maximum “all in a 
moment” and comments on the predisposition of functional patients to develop 
new different symptoms over the time. 
In lecture XXV, he also described a man, who after a physical injury and the 
application of a splint in the arm developed a painful fixed posture with the arm in 
flexion (Figure 2.1).  
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Figure 2.1. Man with fixed dystonia after injury and application of a splint described by 
Charcot in The Clinical Lectures on the Diseases of the Nervous System. Image 
courtesy of the Queen Square Library, Archive and Museum. Copyright National 
Hospital for Neurology & Neurosurgery. 
 
Interestingly, this patient underwent an examination under the effect of 
Chloroform to confirm the hysterical origin and to assess that there were no 
contractures of his muscles or shortening his tendons. This is the first account for 
an examination under anaesthetics (which is still nowadays used with the same 
purposes) that I have come across during my review of the literature. Later on, 
Breuer will also realise that hysterical contractures may disappear under the effect 
of anaesthesia after given Chloral to Anna O.  
Overall, Charcot pursued the regularities and laws of hysteria, derived from its 
clinical manifestations. He asserted that hysterical symptoms "do not form, in 
pathology, a class apart, governed by other physiological laws than the common 
one." (Charcot, 1889). His eagerness to understand the mechanism of hysteria from 
a neurobiological perspective is clearly reflected in his theory to explain hysterical 
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contractures. Firstly, he explained the causes of organic contractures and then, the 
similarities with the functional symptom: “In hemiplegia consequent on a lesion of 
the brain […] the limb remains flaccid. But the contracture exists there, in a latent 
state as it were, as is shown by exaggeration of the tendon-reflexes; and sometimes 
by repeated blows on the patellar tendon, a temporary contracture lasting several 
minutes can be produced. Well, under these circumstances, there is an imminence of 
contracture which can be brought on by the occurrence of a traumatism, and it will 
manifest itself in the part which is the seat of the contusion, sprain etc. […] 
Moreover, to determinate a contracture, the injury need not necessarily be violent. 
The theory which best enables us to fix these facts in the mind is the following: there 
exists in cases of paralysis due to material lesion a hyper-excitability of the grey 
substance, and particularly of the motor cells of the anterior horns, a special state. 
Then, a cutaneous irritation, irritations of the centripetal nerves in general, 
augments the already excited conditions of the motor cells […]. Now, to return to 
hysteria, in many hysterical patients […] exists an exaggerated reflex excitability. 
Hence, it is not astonishing to find that an excitation of the centripetal nerves […] 
produces the same effects as in cases where there exists a lesion of the nervous 
system” (Charcot, 1889). 
In the Clinical Lectures on the Diseases of the Nervous System, Charcot argues for 
the view that hysteria is a brain disease caused by functional rather than structural 
abnormalities. Interestingly, he also advised his students about the difficulties of 
differentiating hysteria from individuals simulating symptoms: “When we are 
treating of hysteria, the physician should always have present in his mind the 
possibility of simulation” (Charcot, 1889). Indeed, he aimed to prove that most 
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patients with hysterical contractures were actually not feigning their symptoms. For 
that, he and his colleagues designed an experiment using the following device 
(Figure 2.2). 
 
 
 
 
 
 
 
 
Figure 2.2. Device to demonstrate that patients with fixed dystonia are not feigning 
described by Charcot at The Clinical Lectures on the Diseases of the Nervous System. 
Image courtesy of the Queen Square Library, Archive and Museum. Copyright National 
Hospital for Neurology & Neurosurgery. 
 
They placed the hand affected by hysterical contractures on a table and submitted 
it to a continuous traction of 1 kg for 30 minutes. They assessed breathing patterns 
with a plethysmograph-like machine over the 30 minutes of the experiment and 
they compared the results with those from a “vigorous” young man who was asked 
to mimic the posture of the patient. Whereas the pattern of breathing of the young 
healthy man changed over the experiment, it became superficial and irregular, 
denoting signs of fatigue, the pattern of hysterics remained stable as if no effort 
was employed.  
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Nevertheless, the physiological view about mechanism of hysteria employed by 
Charcot was not incompatible with more complicated psychological views about 
the aetiology. In 1878 he introduced the technique of hypnotism into this research 
and there was a shift towards acknowledging that psychological factors were also 
relevant (Bogousslavsky, 2011).   
2.4.3 Janet 
Pierre Janet (1859-1947), perhaps due to the influence of his mentor Charcot, also 
developed an avid interest for hysteria.  In the Major Symptoms of Hysteria (1920) 
(Janet, 1907), fifteen lectures given in the Medical School of Harvard University, he 
summarises his thoughts about the underlying mechanism of functional symptoms. 
Interestingly, his view about the personality of patients with hysteric symptoms 
differed radically from the conception that most physicians have nowadays. He 
described hysterics to be “easily managed, not dangerous, on whom we can 
experiment without any great fear and who like to be observed” (Janet, 1907).  
He was one of the first who emphasised the necessity of the early recognition of 
the symptoms and the impact of communicating the diagnosis in the management. 
In one of his lectures he advised the audience: “You must be able quickly to 
recognise this disease, in order to foresee its evolution, to provide against its 
dangers, and immediately to begin a rational treatment. This early diagnosis is 
much more important still from another point of view: it will keep you from making 
blunders. It is perhaps not very serious not to recognise a hysterical accident and not 
to treat it, but what is always very serious is to mistake hysterical accident for 
another one and to treat it for what is not” (Janet, 1907). These words can be 
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interpreted as an attempt to protect patients with functional symptoms from 
unnecessary interventions, if the correct diagnosis is made.  
Janet sought a balance between what he called the theories of the “clinical period”, 
referring to Charcot and contemporaries from 19th century, who, in his opinion, 
tried to give a medical character to hysteria; and what he called “psychological 
period”, meaning by this his contemporaries, who described hysteria as a pure 
mental phenomenon. He criticised Charcot: “[…] carried along by his habits as a 
clinician, he has sought these general laws too much in the physiological domain, 
which led him to a certain number of regrettable errors” (Janet, 1907) but he also 
disagreed with a pure psychological view of hysteria: “A certain number of authors 
have been seduced by the psychological explanation. It seemed to them that the 
mere words “moral” and “thought” were enough to explain everything, and as 
people generally like simple explanations, physicians are too disposed nowadays to 
be content with a vaguely mental explanation. Hysteria, they say, is a psychic 
disease, it is the disease of suggestion, taken in a vague sense […] There is some 
truth in this view, for it brings into relief the psychic character of affection; but it is 
quite insufficient. We should, in my opinion, retain something of the precise method 
of Charcot, of the search after the determination and the laws of hysteria, and apply 
it only to the psychological facts” (Janet, 1907). 
In these lectures he meticulously described the most common FMD: tremor and 
dystonia. 
He stated that in FT tremor “the arm has regular little oscillations, of an average 
rate of five to nine a second. These oscillations are nearly continual. There are some 
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subjects with whom they never stop, either when they rest or when they move; 
there are some others with whom these tremors are intermittent, disappearing at 
the time of voluntary activity and increasing at the time of diversion and rest. But it 
is not possible to establish any rule, for you often observe the reverse in the form of 
intentional trembling, analogous to that of disseminated sclerosis […] These tremors 
occur under various conditions, sometimes gradually, after paralytic phenomena, 
very often suddenly, after an emotion. One of the finest cases I have observed is that 
of a workman, who, in consequence of the breaking of a scaffolding, remained 
suspended at the height of a sixth floor. […] But in most cases, there is nothing 
behind the tremor but a vague emotive state and a kind of transformation of the 
motor function of the limb.” (Janet, 1907) 
He described functional dystonia as “a state of moderate contraction of an 
ensemble of muscles which maintains a limb in a determinate position and that in 
an involuntary, unconscious, and indefinite manner. Such contractures can be 
observed on absolutely all the muscles of the body, and in each region they raise 
medical problems […] First we know that contractures are consequent, like all 
hysteric phenomena, on thoughts and emotional phenomena. A shock has no action 
in this direction except when it determines the great phenomena of imagination, I 
will explain myself.  An individual has his legs in a state of contraction because, he 
says, a carriage ran over them. After verification, it is found that the carriage passed 
besides him, and that he felt nothing at all. A real shock would do less than this 
imaginary shock […] The contracture varies with certain psychological facts. If the 
subject is very quiet, if nobody touches her contractured limb, and if she herself does 
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not try to make a voluntary movement, we may see than contracture decrease…” 
(Janet, 1907).  
Janet highlighted the genuine nature of the symptoms and differentiated them 
from those that were feigned. He stated: “You will find that you are much more 
awkward than a hysteric person, and that unless you have practiced specially to this 
end, you cannot obtain the same regularity. Try to keep your arm in the position of a 
hysteric contracture and describe the movement of the arm; you will remark that 
you have not the same perseverance or courage as the patient. After a short time, 
your arm trembles and is displaced, while the hysteric contracture has not changed. 
If therefore we suppose there is a psychic action in these hysteric phenomena, it 
must be acknowledged that this action is not identical with ours, but that is 
performed in other conditions. Here is my hypothesis; […] “…Action by becoming 
unconscious in hysterics, by separating from consciousness, loses something of its 
dignity, retrograde in a manner and assumes an appearance that recalls the action 
of visceral muscles, the action of the lower animals, and the movements of fatigued 
muscles, as if the activity of the sarcoplasm prevailed over that of the fibrils. This is 
what in my opinion gives to the subconscious action of the hysteric those abnormal 
characteristics we saw in tremors and contractures” (Janet, 1907). 
Overall, Janet summarized the peculiar mental state of hysterical by the words 
“retraction of the field of consciousness”. Janet was one of the originators of the 
idea of dissociation. He proposed that in the physiological state enormous amounts 
of sensory information from all the points of our bodies constantly emerge. 
However, a person never perceives them all. The number of elementary sensations 
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that can simultaneously reach consciousness depends on the extent of the field of 
consciousness and this may differ very much within individuals and depends on 
their state of mind (attention). The sensations which do not reach consciousness 
must remain in the sub-consciousness, and he calls this “normal absent-
mindedness”. In the case of hysterics, the field of consciousness is so contracted 
that the patient reserves the small share of perception for the sensation which is 
considerate the most important one. For instance, if patients can perceive just two 
stimuli at the same time and vision and auditory stimuli are prioritised, when 
someone pinches the left arm of the patient, he cannot feel it consciously: it has 
become anaesthetic. He considered that this restriction of the field of 
consciousness was secondary to their fundamental mental state, which was 
characterised by a “special moral weakness, consisting in the lack of power, on the 
part of the feeble subject, to gather, to condense his physiological phenomena and 
assimilate them to his personality” (Janet, 1907). 
Janet’s theory accounted essentially for functional anaesthesia and he found it 
more difficult to explain other functional symptoms.  
Janet also emphasised the importance of physical events preceding the onset of 
functional symptoms. He believed that the restriction of the field of consciousness 
usually affected a function that for some reason or other had become weak. He 
gave examples of cases such as that of a girl with functional paralysis in her right 
leg, and he believed that the reason was that in her childhood the right leg was 
affected with rachitis or the case of another girl with paralysis of the leg, which was 
thought to be due to the fact that in her childhood the leg was affected by a tumour 
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and was kept wrapped in a bandage (Janet, 1907). He also brought to attention 
what nowadays is called “functional overlay” by saying that “in certain cases, 
hysteria makes conspicuous some light symptoms of organic disease of the nervous 
system quite at the beginning by exaggerating them beyond all measures” (Janet, 
1907). 
2.4.4 Freud 
In popular culture hysteria begins and ends with Sigmund Freud (1856-1939). 
However, as previously reviewed, there is a tradition of study of hysterical 
symptoms for more than three thousand year history before his work. Despite 
being a pupil of Charcot in Paris, Freud rejected any account for hysteria but the 
pure psychological one. This strong theoretical position is well reflected in Studies 
on Hysteria (1893-1895) (Breuer and Freud, 1974), a book written with his mentor 
in Vienna: Joseph Breuer. Here, they wrote “in what follows, little mention will be 
made of the brain and none whatever of molecules. Physical processes will be dealt 
with in the language of psychology; and indeed it cannot possibly be otherwise”.  
The purpose of their work was to elucidate the precipitating cause of hysteria, “the 
event which provided the first occurrence after many years earlier of the 
phenomena in question”. They acknowledged the difficulties that go with it as “the 
patient sometimes dislikes discussing, and mainly because they are genuinely 
unable to recollect it and has no suspicion of the causal connection between the 
precipitating event and the pathological phenomenon.”  
It was clear to me on reading this text that they recognized physical precipitating 
factors close to the onset of the functional symptoms in several clinical cases 
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through the book. For instance, in the famous case of Anna O they wrote “a girl, 
watching beside a sick-bed in a torment of anxiety, fell into a twilight state and had 
a terrifying hallucination, while her right arm, which was over the back of her chair 
went to sleep; from this, she developed a paresis of the same arm accompanied by 
contracture and anaesthesia” (Breuer  and Freud, 1974). It is possible that in first 
place, Anna had numbness and a degree of paresis secondary to nerve compression 
caused by placing her arm on a hard surface (the back of a chair) for a number of 
hours. Or the case of Miss Lucy R, a girl who suffered from suppurative rhinitis and 
necrosis of the ethmoid bone and developed later hysterical symptoms in the form 
of subjective olfactory sensations (Breuer and Freud, 1974).  By observations like 
these, they proposed that the concept of traumatic neurosis from Charcot should 
be extended to traumatic hysteria. Here, it is not the physical injury but the affect 
of fright that commonly accompanies the injury, the psychical trauma, which is 
considered the cause of the illness. They neglected the importance of the physical 
event itself by saying that their investigations reveals “for many, if not for most 
hysterical symptoms, precipitating causes [can be identified] which can only 
described as psychical traumas.” (Breuer and Freud, 1974)   
When it was not possible to establish the point of origin of the illness, they 
hypnotized the patient “As a rule it is necessary to hypnotize the patient and to 
arouse his memories under hypnosis of the time at which the symptom made its first 
appearance” (Breuer and Freud, 1974) and when patients denied any precipitant or 
the one interpreted by them, they attempted to persuade the patients to believe 
the opposite.  
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In the theoretical part of the Studies on hysteria, they summarize their views after 
the observation of several hysterical patients. They use the analogy of an electrical 
system through which there is a constant flow of current to explain what may 
happen in the brain. In physiological conditions, they argued that the brain tries to 
keep in a constant excitation “intracerebral tonic excitation” at that level which is 
optimal to be “accessible to all external stimuli, the reflexes are facilitated, though 
only to the extent of normal reflex activity, and the store of ideas is capable of being 
aroused and open to association in the mutual relation between individual ideas 
which corresponds to a clear and reasonable state of mind” (Breuer and Freud, 
1974). Healthy people can get rid of any increased cerebral excitation associated to 
emotional situations by using motor discharge or secretions (for instance shouting 
and jumping for joy or sobs and tears when sadness). If these reactions are 
suppressed, the affect associated with emotional situations is not “abreacted” and 
may remain attached to the memory (Breuer and Freud, 1974).  
Coming back to the analogy with an electrical system, they argue that there must 
be resistances through the system, which prevent the general distribution of 
excitation (mainly in organs which are of vital importance “the circulatory and 
digestive organs are separated by strong resistances from the organs of ideation”). 
The strength of these resistances varies from one person to another and they 
suggested that this is the explanation why some people have a strong vegetative 
reaction with low levels of stress and others do not (Breuer and Freud, 1974).  
In the case of hysterics, Breuer and Freud argued that they have an innate 
idiosyncrasy which is characterised by excess of energy. They understood hysterics 
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as lively people, full of intellectual interests before they fall ill. They thought that it 
was uncommon “to find in them simply, dull intellectual inertia”. During puberty the 
original excess is increased by additional excitation which arises with the 
emergence of sexuality.  After puberty, they have enormous quantity of free 
nervous energy available for the production of pathological phenomena. But this 
predisposition to hysteria does not lie down exclusively on excessive intracerebral 
excitation. Hysterics were also thought to have abnormal weakness of the 
resistances. These weak resistances were suggested to be determined by the 
individual's initial constitution, by the long-term excitation itself or by weakening 
factors, such as the presence of a previous illness of the organ concerned, which 
may facilitate the paths to and from the brain (Breuer and Freud, 1974).  
They suggested that in hysteria, there are difficulties to abreact traumatic 
experiences and memories of these experiences are repressed from their 
consciousness. These memories, which have a strong affect attached to them, 
increase the excitation of the brain and this energy is “converted” into a somatic 
phenomenon. This discharge “follows ‘the principle of least resistance’ and takes 
place along those paths whose resistances have already been weakened by 
concurrent circumstances” (Breuer and Freud, 1974). For instance, in the case of 
Miss Lucy R, hysteric symptoms were subjective olfactory sensations and she had 
recently suffered from suppurative rhinitis that might have acted as a weakening 
factor. 
Their therapeutic approach was the use of light hypnosis and suggestion to bring 
back to consciousness the memory of the traumatic event and arousing its 
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accompanying affect. They assured readers that when patients had described the 
event in the greatest possible detail and had put the affect into words, the 
symptom immediately and permanently disappeared. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  
64 
 
Chapter 3: Aims and hypotheses 
The background above provides, I hope, a picture of how theories regarding the 
pathophysiology of functional symptoms have largely focussed on causation (and 
here have focussed on causation by a psychological trauma), and less on the 
mechanism by which this event becomes translated into the type of physical 
symptom experienced by the patient. In other words there has been a focus on 
“why” rather than “how” symptoms develop. While I believe both questions are 
very important, my sense at the beginning of the work was that the question of 
“how” symptoms are produced might be more tractable and relevant. The other 
key factor that helped in the formulation of the hypotheses I pursued was the 
patient population that I had access to. These patients had disorders of movement, 
providing a great opportunity to study symptoms where there are observable 
clinical signs (in comparison to sensory loss or pain for example). The clinical 
methods for making a diagnosis in such patients already provided key information 
on the likely underlying mechanism, especially with regard to the importance of 
attention. I therefore took as my starting point the manner in which the diagnosis 
of FMD is made in neurological practice. The diagnosis can be made confidently on 
the basis of positive physical signs, helped by certain historical features. This, to me, 
was the most suitable starting point as it removed aetiological speculation, 
particularly about the role of psychological trauma in causation of functional 
symptoms, and instead focused on a more mechanistic level. This provided a better 
fit with investigation of other illnesses where the main tractable areas of study (at 
least initially) relate to how symptoms are produced, rather than why.  
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In addition to a clear role for attention in the generation of functional motor 
symptoms being apparent from a clinical point of view, two other potentially 
important mechanistic issues stood out for me. One was that some symptoms (for 
example tubular visual fields) suggested a key role for beliefs about the way the 
nervous system might malfunction due to illness which we know are contradicted 
by basic anatomy and physiology. The other issue was that there must be an 
abnormality in sense of agency for movement if movement that appears to be 
voluntarily generated is not experienced as such. Finally, I was also interested in 
understanding better the circumstances surrounding the onset of the functional 
symptoms.  
I looked for paradigms that might provide ways of exploring these three areas of 
interest, and in this I was influenced in part by paradigms that had been previously 
used in patients with delusional beliefs. It was against this background that I 
developed the following hypotheses: 
1. That physical precipitating factors will be common in patients with FMD, as 
our clinical experience suggested. 
2. That patients with FMD will display a reasoning style different to healthy 
controls that may predispose them to accept new hypothesis on the basis of 
less evidence.   
3. That patients with FMD will have impaired motor control under 
circumstances in which there is an opportunity for attention to be directed 
towards movement production. 
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4. That patients with FMD will display abnormalities in paradigms designed to 
assess the sense of agency for movement. 
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Chapter 4: A study on the physical precipitating factors 
in functional movement disorders 
The work presented in this chapter was originally published in the form of a research article: 
Pareés I, Kojovic M, Pires I, Rubio-Agusti I, Saifee TA, Sadnicka A, Kassavetis P, Macerollo A, 
Bhatia KP, Carson A, Stone J, Edwards MJ. Physical precipitating factors in functional 
movement disorders. Journal of Neurological Sciences. 2014 Mar 15; 338(1-2):174-7. 
4.1 Introduction 
We have seen that typically, functional neurological symptoms, including FMD, 
have been explained as resulting from psychological stressors which lead to 
unconsciously produced physical symptoms. In keeping with this formulation, 
several authors have found higher rates of childhood trauma in patients with 
functional symptoms (Alper et al., 1993, Bowman and Markand, 1996, Roelofs et 
al., 2002) or have highlighted the aetiological importance of emotional stress or 
recent life events (Binzer et al., 1997, American Psychiatry Association, 2000, Irfan 
and Badar, 2002). Indeed, it was not possible to make a diagnosis of conversion 
disorder according to the Diagnostic and Statistical Manual of Mental Disorders 
(DSM) IV criteria without the presence of a psychological stressor that precedes the 
onset of physical symptoms (American Psychiatry Association, 2000).   
My impression from my involvement in a specialised clinic for FMD was that many 
patients did not report psychological stressors prior to the onset of symptoms. 
Supporting this view, a recent study found few differences in self-reported recent 
life events or past experience of sexual or physical abuse in patients with FMD, 
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compared to healthy controls and patients with “organic” movement disorders 
(Kranick et al., 2011).  
In contrast, my experience was that many patients with FMD reported a physical 
event such as injury or illness at the time of onset of their symptoms. The presence 
of a physical event was discussed as part of the pathophysiology of FMD at the time 
of Charcot, who coined for instance the term “traumatic dystonia” to describe 
hysteric contractures after minor injuries, but since then, the role of physical events 
triggering functional symptoms has been neglected in favour of more psychological 
explanations.  
After a search of the published literature for the past 25 years, I realised that 
physical events had been commonly reported in cohort studies of FMD but they 
had only very rarely been discussed in research articles and had been ignored as a 
relevant factor for symptoms development. I summarise this data in Table 4.1. 
  
Table 4.1. Examples of studies where physical precipitating factors have been reported in 
functional movement disorders 
Author, year Type of study N Subjects Main FMD Patients  
with PPF, 
n (%) 
Type of PPF (no. of  
patients, where  
available) 
Koller et al.,  
1989 
Retrospective 24 Adults Tremor 11 (45.8)  Head injury (2) 
 Flu-like illness (2) 
 Motor vehicle accident (3) 
 Exposure to Agent Orange (1) 
 Respiratory infection (1) 
 Abdominal surgery (1) 
 Vomiting (1) 
Ranawaya et al., 
1990 
Uncertain 6 Adults Dyskinesia 6 (100)  Spasmodic torticollis (2) 
 Writer’s cramp (1) 
 Whiplash injury (1) 
 Road traffic accident (1) 
 ‘Pre-existing organic 
movement disorder’ (1) 
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Monday and 
Jankovic, 1993 
Retrospective 18 Adults Myoclonus 9 (50)  Injuries at work (3) 
 Flu-like symptoms (3) 
 Motor vehicle accident (2) 
  ‘Slipped in a shopping  
mall’ (1) 
Factor et al.,  
1995 
Retrospective 28 Adults Mixed 13 (46.4)  Back injury (4) 
 Back surgery (1) 
 Fell off ladder (1) 
 Motor vehicle accident (2) 
 Carpal tunnel syndrome (1) 
 Hand caught in a bus door (1) 
 Exposure to polyvinyl-alcohol 
and trichloroethylene (1) 
 Worsening medical  
condition (1) 
 Taking erroneous  
prescription drug (1) 
Factor et al.,  
1995 
Retrospective 14 Adults Parkinsonism 10 (71.4)  Febrile illness (1) 
 Work injury (3) 
 Motor vehicle accident (2) 
 Head injury and subdural 
haematoma (1) 
 Pregnancy (1) 
 ‘Fibrositis’ (1) 
 Exposure Agent Orange? (1) 
Lang, 1995 Retrospective 18 Adults Dystonia 14 (77.8)  Febrile illness (1) 
 Hand surgery (1) 
 Minor head injury (1) 
 Motor vehicle accident (5) 
 Work injury (1) 
 Walking (1) 
 ‘Injury’ (1) 
 HIV (1) 
 Fall (1) 
 Fracture (1) 
Deuschl et al., 
1998 
Prospective 25 Adults Tremor 12 (48)  Lumbalgia (2) 
 Neck pain (3) 
 Periarthropathia 
humeroscapularis (1) 
 Myocardial infarction (1) 
 Asthma (1) 
 Shell shock (1) 
 Mild cervical trauma (1) 
 Meningoencephalitis (1)  
 Fracture (1) 
Kim et al., 1999 Retrospective 70 Adults Tremor 23 (32.8)  Physical injury (23) 
Verdugo and 
Ochoa, 2000 
Prospective 58 Adults Dystonia, 
tremor 
55 (94.8)  Physical injury (55) 
Feinstein et al., 
2001 
Prospective 42 Adults Mixed 21 (50)  Surgery (8) 
 Road traffic accident (7) 
 Injury (5) 
 Infection (1) 
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Tan and  
Jankovic, 2001
 
Retrospective 5 Adults Hemifacial 
spasm 
1 (20)  Head injury (1) 
Schrag et al.,  
2004 
Retrospective 103 Adults Fixed  
dystonia 
76 (73.8)  Peripheral injury or back or 
neck injury (65) 
 Arthroscopy (2) 
 Fracture (1) 
 Pain (2) 
 Head injury (1) 
 Asthma (2) 
 Abscesses on thigh (1) 
 ‘While in physiotherapy’ (1) 
 Tingling and weakness  
in legs (1) 
Jankovic et al., 
2006 
Retrospective 127 Adults Tremor 70 (55.1)  Trauma (30) 
 Surgery (12) 
 Major illness (17) 
 Reaction to medical 
treatment/procedure (11) 
Benaderette et al., 
2006 
Prospective 9 Adults Parkinsonism 3 (33.3)  Accidental fall at work (2) 
 Surgery (1) 
Espay et al.,  
2006
 
Prospective 10 Adults Dystonia 7 (70)  Motor vehicle accident (3) 
 Falling in the bathroom (1) 
 Chiropractic manipulation (1) 
 Ankle sprain (1) 
 Fatigue (1) 
Baik and Lang, 
2007 
Retrospective 279 Children, 
adults 
Mixed 68 (24.4)  Motor vehicle accident 
 Surgical procedure 
Ferrara and 
Jankovic, 2008 
Retrospective 54 Children Mixed 29 (53.7)  Injury or accident (19) 
 Minor medical illness  
(e.g. pharyngitis) (5) 
 Exertion (5) 
McKeon et al., 
2009 
Prospective 33 Adults Tremor 8 (24.2)  Medical procedure 
 Respiratory infection 
 Back pain 
Stamelou et al., 
2012 
Retrospective 7 Adults Palatal tremor 7 (100)  Flu-like illness (1) 
 Viral labyrinthitis (1) 
 Tinnitus (1) 
 Otitis (1) 
 Endoscopy (1) 
 Vomiting (1) 
 Throat infection (1) 
Canavese et al., 
2012 
Retrospective 14 Children Mixed 1 (7.1)  Minor teeth surgery (1) 
Fasano et al.,  
2012 
Retrospective 61 Adults Facial FMD 25 (41)  Physical trauma (9) 
 Peripheral facial  
injury (8) 
 Pain (3) 
 ‘Another disease’ (5) 
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Only one study, which is a review of previous literature about the role of physical 
injuries in motor and sensory functional symptoms in general, reported that 34% of 
patients with FMD had a recent history of physical injury and emphasized the 
potential role in symptoms generation (Stone et al., 2009). The proportion of 
physical injuries preceding the onset of the symptom was lower for FMD than those 
reported for functional sensory loss (45%) and functional paralysis (41%) in this 
study (Stone et al., 2009). 
Based on this previous information, we I aimed for the first time to systematically 
describe physical events (not just physical injuries), which occurred at the onset of 
functional symptoms in a cohort of 50 consecutive patients with FMD, as well as 
exploring other events near to onset.  
4.2 Methods 
4.2.1 Participants 
Fifty patients were recruited in a consecutive way from a specialised Functional 
Movement Disorder run by Dr Edwards, at the NHNN Queen Square, London, UK, 
from January 2011 until December 2011.  
I used as inclusion criteria: 
1. Newly referred patient. 
Batla et al.,  
2013 
Retrospective 151 Adults Mixed 52 (33.4)  Trauma (34) 
 Surgery (9) 
 Infection (9) 
FMD = functional movement disorder; PPF = physical precipitating factor 
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2. Age over 18 years.  
3. Diagnosis of clinically established or documented functional movement 
disorders according to Fahn and Williams criteria (Fahn and Williams, 1988).  
I used as exclusion criteria: 
1. Age less than 18. 
2. Unable to communicate with researcher (e.g. does not speak English). 
4.2.2 Semi-structured interviews 
We used face to face semi-structured interviews to characterise the circumstances 
which surrounded the onset of FMD. We used this type of interview because, 
although it was more time consuming than a structured interview and harder to 
analyse, it is more flexible and allowed us to collect more detailed data. The 
interviews were carried out by Dr Edwards and myself. I designed the data 
collection sheet in which information on sex, age, marital status, presenting 
symptoms, work status, presence of a disease model either at work or among 
family and friends, receipt of financial benefits and the presence of litigation were 
recorded. The interview also provided a retrospective account of the tempo of 
onset, associated symptoms and circumstances prior to onset of the FMD, which 
were also recorded.  
There is no consensus about the timing between a precipitating event and the 
onset of a FMD to be sure that there is a good chance that there is a causal 
relationship.  Some authors have considered one year between a physical injury 
and the development for instance of functional dystonia. Others consider this gap 
excessive and have reported that most triggers occur within the first few months.  
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In this study, only physical events within 3 months before the onset of the FMD 
have been included for consideration. 
We used DSM-IV criteria for panic disorder (Box 2) to describe the presence of 
panic symptoms at the onset of symptoms (American Psychiatry Association, 2000). 
  
Box 2. DSM-IV criteria for panic attack 
A discrete period of intense fear or discomfort, in which 4 (or more) of the 
following symptoms developed abruptly and reached a peak within 10 
minutes: 
1. Palpitations, pounding heart or accelerated heart rate 
2. Sweating 
3. Trembling or shaking 
4. Sensations of shortness of breath or smothering 
5. Feeling of choking 
6. Chest pain or discomfort 
7. Nausea or abdominal distress 
8. Feeling dizzy, unsteady, light headed or faint 
9. Derealisation or depersonalisation  
10. Fear of losing control or going crazy 
11. Fear of dying 
12. Paresthesias  
13. Chills or hot flushes 
 
4.2.3 Questionnaires 
Following the interview, I asked participants to complete two questionnaires 
regarding their mood and the presence of life events within the 3 months prior to 
the onset of the FMD. When it was not possible for the patients to do it in the clinic, 
they were allowed to take away the questionnaires and send them back by post if 
they wished. For those patients who failed to return the questionnaires in two 
weeks, I phoned them as a reminder.  
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4.2.3.1 Mood 
We used The Hospital Anxiety and Depression rating scale (HADS) with reference to 
their mood the week prior to testing (Zigmond and Snaith, 1983). There are 7 items 
for anxiety and 7 for depression. Each item is scored on a 0-3 scale. Therefore, the 
potential range of scores is 0-21 for both anxiety and depression scales, with higher 
scores indicating greater emotional disturbance. A cut off level of 9 or more has 
been found to have similar sensitivity and specificity in cancer patients.  We used 
HADS because it is brief and simple to administer and although it was originally 
designed to be used with hospital populations, it has been found to perform well 
with non-hospital groups. 
4.2.3.2 Life events 
We used the 82 items Life Events Questionnaire (LEQ) (Norbeck, 1984). This is a 
self-report questionnaire addressing life events in the categories of health, work, 
school, residence, love and marriage, family and close friends, parenting, personal 
or social, financial and crime or legal matters. Patients are asked to indicate 
whether each event is considered “good” or “bad”; and rate the impact of the 
event on a 4-point scale (0-3). We used the negative events score (the sum of the 
impact ratings for all items designated as "bad" by the patient: range from 0 (no 
impact) to a maximum of 246). We chose this 82 items questionnaire because it 
covers a broad range of life event and includes questions that increase the 
relevance for adult female respondents of childbearing age, a group which was 
predicted to be common in our cohort. 
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4.3 Results 
We recruited 11 males and 39 females. Demographic and clinical characteristics are 
shown in Table 4.2. 
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Table 4.2. Demographic characteristics of the patients (n = 50) 
Age (years), mean (SD) 39.8 (11.9) 
Gender, n (%) 
   Female 
   Male 
 
39 (78) 
11 (22) 
Marital status, n (%) 
   Single 
   Cohabiting/married 
   Divorced 
 
19 (38) 
27 (54) 
4 (8) 
Educational level, n (%) 
   ≤16 years 
   To 18 years 
   Graduate 
 
22 (44) 
17 (34) 
11 (22) 
Current employment status, n (%) 
   Employed  
   Unemployed 
   Off sick  
   Medically retired  
   Student  
   Unknown  
 
8 (16) 
8 (16) 
11(22) 
16 (32) 
3 (6) 
4 (8) 
Symptoms duration (years), mean (SD) 5.7 (6.1) 
Type of FMD, n (%) 
   Fixed dystonia 
   Tremor 
   Myoclonus 
   Mobile dystonia 
   Paroxysmal FMD with retained consciousness  
   Parkinsonism 
   Gait disturbance 
   Tics 
   Combination of  ≥2 FMD 
 
15 (30) 
8 (16) 
4 (8) 
3 (6) 
2 (4) 
1 (2) 
1 (2) 
1 (2) 
15 (30) 
Potential sources of symptom modelling, n (%) 
   Health care worker  
   Family/friends  
   Both  
 
8 (16) 
10 (20) 
2 (4) 
Home disability adaptations, n (%) 21 (42) 
Family acting as a career, n (%) 34 (68) 
Benefits, n (%) 25 (50) 
Litigation, n (%) 3 (6) 
FMD = Functional Movement Disorder; SD = standard deviation 
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4.3.1 Tempo of onset 
Twenty seven patients (54%) reported a sudden onset of symptoms (seconds-
minutes).  Eighteen patients (36%) developed symptoms in hours - 1 day and only 5 
patients reported a gradual onset (more than 1 day to maximal symptoms).  
4.3.2 Physical precipitating factors 
From a total of 50 patients, 40 (80%) patients reported a physical event within the 
three months prior to the onset of the FMD. Three patients did report a physical 
event which was related to the functional symptom (injuries in the same limb 
where the FMD appeared) but these occurred before the 3 months period that we 
set as inclusion criteria. One patient did not remember the exact timing between 
the physical event and the onset of the symptoms. 
Time from physical event to onset of FMD in those 41 patients was minutes in 8 
(16%) patients, approximately one day in 6 (12%) patients, two days in 4 (8%) 
patients, within the first week in 7 (14%) patients, one month in 9 (18%) patients 
and within the 3 months prior to onset in 6 (13%) patients. 
The FMD occurred after an injury in 11 (22%) patients. The injuries were mainly of 
soft tissues, but some patients experienced more serious injury leading to fracture. 
In 9 (18%) patients, FMD first started after an infection, most commonly a flu-like 
illness. In another 8 (16%) patients functional symptoms appeared following a 
neurological disorder (severe episode of migraine (n=3), brachial neuritis (n=1), 
Bell’s palsy (n=1), carpal tunnel syndrome (n=1), restless legs syndrome (n=1) and 
after a pituitary haemorrhage (n=1)). In 4 (8%) patients, pain appeared to be an 
important factor at onset (either an episode of acute pain even though there was 
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no specific injury, or exacerbation of chronic pain). Three (6%) patients presented 
with functional symptoms after experiencing a drug reaction, two of them after an 
acute dystonic reaction secondary to dopamine receptor blockers used as 
antiemetic and one patient after jerks induced by fluoxetine. Three (6%) patients 
developed FMD after major surgery (tendon transfer operation, surgery to relieve 
cauda equina syndrome and a tensor fascia lata release). Finally, 2 (4%) patients 
developed FMD after an episode of vasovagal syncope. We sought associations 
between types of physical event and subsequent functional phenomenology but no 
clear relationship was found (Table 4.3). 
 
Table 4.3. Number of patients with a particular physical precipitating factor for each type of 
functional movement disorder (n = 50) 
 Operation Physical 
injury 
Drug 
reaction 
Infection Neurolo-
logical 
disease 
Vasovagal Pain None 
Fixed dystonia 3 3 0 4 2 0 1 1 
Tremor 0 1 0 1 2 1 2 1 
Myoclonus 0 3 0 1 0 0 0 0 
Mobile dystonia 0 0 2 0 0 0 0 0 
Paroxysmal FMD 
with retained 
consciousness 
0 0 0 0 0 1 1 0 
Parkinsonism 0 0 0 0 1 0 0 0 
Gait disturbance 0 0 0 1 0 0 0 0 
Tics 0 1 0 0 0 0 0 0 
Combination of  
 ≥ 2 FMD 
0 3 1 2 3 0 0 4 
FMD = functional movement disorder 
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4.3.3 Case examples 
4.3.3.1 Case 1 
This 34-year-old gentleman was fit and well until February 2010 when he was at 
work and started to feel sick and light headed. He was diagnosed with a "sickness 
bug" and was prescribed prochlorperazine to be taken four times a day. By the 
following morning when he had taken four doses or so of the medication he noticed 
the beginning of abnormal movements. This started with twitching and tightening 
of the left arm so that it moved out at the shoulder. He continued to take the 
tablets, but the movement problems worsened and progressed to his legs stiffening 
and moving involuntarily as well as jerking of his head backwards. He remembers 
his throat and face feeling tight and he developed involuntary tongue protrusion. 
He went to the minor injury unit on the following morning but he was told to seek 
advice from his GP again in a few days. No advice was given to stop medication. He 
continued with the drugs and movement problems worsened. When he saw his GP, 
he was told he had had a medication reaction and was advised to stop taking the 
drug which he did right away.  
His movements persisted and he again attended A &E where blood tests were 
taken. He recalled being asked whether he had taken any illicit drugs and he was 
given diazepam which decreased the severity of some of his movements.  
About four weeks after the onset of symptoms he had the first episode of what 
later became regular attacks of abnormal movements. He developed spasms 
around the face and arms and severe gait disturbance. By this time, the original 
movement disorder had almost completely resolved. Attacks could last from 10 
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minutes to 2 hours. He retained consciousness throughout these attacks. He was 
admitted and various investigations were performed including imaging and an EEG 
and no abnormality was found. He was discharged still on treatment with 
Clonazepam. He continued to have attacks on most days. A few months later, he 
had his worst ever attack which occurred at work. He became unable to speak and 
also had a period of time lasting a couple of weeks where he was virtually unable to 
walk. During this time, he received psychological input but he did not feel that the 
emphasis on potential psychological triggering factors were of much relevance to 
him. Our formulation was that he had experienced some extrapyramidal side 
effects from prochlorperazine which had settled within days of the initial reaction 
but which had triggered a functional movement disorder'. 
4.3.3.2 Case 2 
This 59 year old lady who previously worked as a child-minder attended our Clinic. 
Ten years previously she had painful bunions on both feet and had an operation to 
help with this. Post operatively both feet became infected and for unclear reasons 
both legs below the knees were put in plaster for about 7 weeks. When the plaster 
was taken off she had a problem with going over on her ankles when she was 
walking. Because of this, she underwent a bilateral tendon transfer operation. The 
right leg improved, but on the left immediately post-operatively she developed a 
fixed abnormal posture of the foot which on examination had typical features of 
functional fixed dystonia. 
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4.3.4 Panic symptoms 
Most patients reported physical symptoms of panic at the onset of the FMD, which 
were concurrent with the functional symptoms in the majority of them. Eighteen 
(38%) fulfilled criteria for panic attack. Of those, 10 (55%) had an onset of the 
functional symptoms in seconds/minutes and 7 (39%) had an onset in hours/day. 
4.3.5 HADS 
Twenty nine (58%) patients completed the HADS (Zigmond and Snaith, 1983). Mean 
score for depression was 11.8 ±4.6 and mean score for anxiety was 6.7 ±3.8. 
4.3.6 Life events 
Twenty eight (56%) patients filled the in LEQ (Norbeck, 1984). The mean negative 
score for life events within three months before symptom onset was 15.7±16.6 
(maximum score 246). Figure 4.1 shows the characteristics of life events 
experienced among patients. 14% of the patients that completed the questionnaire 
did not report any life event, and 21% reported life events exclusively related to 
health issues. 
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Figure 4.1. Mean negative events scores (in points) across the patients for each of the 
categories recorded in the Life Event Questionnaire. The range of possible points for 
each category is given along the name. 
 
4.4 Discussion 
In this case series, I assessed the presence of physical events preceding the onset of 
FMD in 50 consecutive patients. Eighty per cent of patients described a physical 
event temporally related to the onset of the FMD. Physical injuries were the most 
common precipitating event prior to the onset of the functional illness, as 
previously reported in the literature (Stone et al., 2009). However, a range of other 
physical events including infections, drug reactions and episodes of acute or 
exacerbated chronic pain were commonly associated with onset of FMD. There 
were examples where the phenomenology of the functional symptoms was 
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plausibly related with the physical trigger. For example two patients who had a 
clear acute dystonic reaction secondary to drugs developed a functional dystonia 
which affected the same body parts as the original acute dystonic reaction. Also, 
most patients with fixed dystonia developed symptoms in the limb that was injured, 
where surgery had been performed or where neurological symptoms were present 
(e.g. from brachial neuritis or carpal tunnel syndrome). This is in line with other 
reports suggesting that the nature of the physical precipitating and the affected 
body parts during the physical illness may influence the subsequent functional 
symptom (Moss-Morris and Spence, 2006). For instance, a prospective study 
showed that during follow up, patients who had suffered from Campylobacter 
gastroenteritis had a greater risk for developing irritable bowel syndrome than 
those who had an infectious mononucleosis, whereas infectious mononucleosis 
patients had more significant risk to develop chronic fatigue (Moss-Morris and 
Spence, 2006). We may remember that this potential association was also noted by 
Breuer and Freud, for instance when they described the patient suffering from 
hysteric olfactory symptoms, who previously had had severe infections of the nasal 
cavity (Breuer and Freud, 1974). 
Others have highlighted the occurrence and potential aetiological importance of 
physical events preceding onset of functional neurological symptoms for example 
physical injury to the limb which commonly precedes the onset of limb paralysis 
(Stone et al., 2010).  
As I have previously mentioned, in a review of the literature, it was suggested that 
physical events were more common in functional paralysis (41%) than in FMD (34%) 
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but physical events in these studies were limited to physical injuries. Our results 
suggest that a broader spectrum of physical events might be present at the onset of 
FMD. 
We found that 38% of patients with FMD fulfilled criteria for the diagnosis of a 
panic attack during the physical triggering event, which is similar to that found in 
patients with functional paralysis (34% of 107) (Stone et al., 2010). Similar to 
patients with functional paralysis, most patients who fulfilled criteria of a panic 
attack had an acute onset of the functional symptoms, suggesting a potential link. 
Because of the uncontrolled design of our study we cannot conclude with 
confidence that the physical events reported were causal in the development of 
FMD.  We only can conclude that most patients with FMD report a physical event 
before the onset of the functional symptoms, and this is often accompanied by 
physical symptoms of a panic attack. We hypothesise that physical events can be of 
relevance themselves in the development of functional symptoms by providing new 
sensory data which may be abnormally processed and could provide the substrate 
for the development of an abnormal movement.  However, most people do not 
develop FMD after common physical events such as injuries or flu-like illness. 
Therefore, there should be other predisposing factors, perhaps at a cognitive level, 
which may influence the way initial sensory data is processed.  
The presence of symptoms related to panic during the physical triggering event may 
play also a role. It may provide an additional factor that could increase the salience 
of the sensory information occurring during a coincident physical precipitating 
event or could generate additional physical symptoms in itself (e.g. tremor).  
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There is clearly still a role for past and recent life events in generating vulnerability 
in individual patients. In addition, no physical event can be experienced without a 
concomitant psychological experience. Our impression is that in many patients it is 
the physical triggering event itself which may be best thought of as the most 
important “recent stressor” related to the symptom, rather than hunting in the 
history for an emotional life event which reflects the general vulnerability of the 
patient.  
In this regard, we assessed the presence of life events three months prior to the 
onset of the functional symptoms by using a self-report questionnaire (LEQ) 
(Norbeck, 1984), which addressed several categories. We found that patients 
scored low in the negative score for life events within three months before 
symptom onset (15.7±16.6), which is similar to the score reported by others, for 
instance in patients with colon polyps and normal controls (Ashktorab et al., 2013). 
A sizable proportion of patients who reported life events mainly scored in the 
health-related subscore, which linked with the high proportion reporting a physical 
precipitating factor. This is in line with other studies of patients with FMD and other 
functional neurological symptoms where patients do not commonly report adverse 
life events (other than those associated with their physical health) close to onset of 
FMD (Binzer et al., 1997, Kranick et al., 2011). However, it should be noted that the 
retrospective assessment of life events is difficult especially with regard to recall 
bias. This, along with the low response rate that we obtained for the LEQ 
questionnaire, does not allow us to draw clear conclusions about the presence of 
potential psychological stressors.  
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I acknowledge a number of other methodological limitations. First, we did not 
include a control group and our result should be interpreted with caution in terms 
of causality. The ideal control population would have been “organic” movement 
disorder counterparts with a sudden onset. However, the vast majority of “organic” 
movement disorders start gradually and this made any attempt at comparison 
difficult. Second, there is the problem of recall bias. We cannot rule out that 
patients have over reported physical events and/or under reported life events at 
the onset of the FMD. In this regards, alexithymia has recently been found to be 
common in patients with functional motor symptoms (Demartini et al., 2014). We 
cannot rule out that potential difficulties to identify emotions were also influencing 
the results of the LEQ.   Also, the retrospective design of the study has difficulties 
distinguishing a physical event and onset of functional symptoms.  Third, because 
patients were recruited in a specialist centre, one can argue that the data may not 
be representative of all patients with FMD. However, I do not feel that the clinical 
histories of the patients we included significantly differ from case series of patients 
with FMD collected from less specialist services. In addition, recruitment was 
consecutive in order to minimize a selection bias. Fourth, the response rate for 
questionnaires was low, which makes it difficult to comment on more psychological 
aspects. Fifth, we set an arbitrary limit of 3 months for both physical events and life 
events to be included. A specific timing is not well established but we believe that 
with this selection, we have assured a reasonable temporal relationship.  
In summary, physical triggering events are common in FMD and an appreciation of 
their role may help to move forward our understanding of the mechanism of FMD 
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beyond simplistic notions related to “psychological stressors” towards a more truly 
biopsychosocial model of these common and disabling symptoms.  
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Chapter 5: A study on the “jumping to conclusions” bias 
in functional movement disorders 
The work presented in this chapter was originally published in the form of a research article: 
Pareés I, Kassavetis P, Saifee TA, Sadnicka A, Bhatia KP, Fotopoulou A, Edwards MJ. 
'Jumping to conclusions' bias in functional movement disorders. Journal Neurology 
Neurosurgery and Psychiatry 2012; 83: 460-3. This is available online at 
http://jnnp.bmj.com/content/83/4/460.long 
5.1 Introduction 
In the previous chapter, we have seen that most patients with FMD report a 
physical event temporarily close to the onset of the functional symptoms which 
often are phenomenologically related. We suggested that they may be of relevance 
in symptom development by providing new sensory information which may be the 
substrate for the functional symptom in question. However, the physical events 
that we reported, particularly painful injury or flu-like illness, are almost universal 
occurrences that do not trigger functional symptoms in most people who 
experience them. Therefore, I wondered whether there should be differences in the 
manner in which patients process novel information and use it to guide future 
behaviour.  
As a preliminary exploration of this question I assessed a well-known cognitive 
reasoning model in psychiatric research, the “jumping-to-conclusions” (JTC) bias. 
For that, I used the “bead task” (Garety et al., 1991). In this paradigm, participants 
assess (within a Bayesian reasoning framework) the probabilities of events on the 
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basis of empirical evidence. Deluded patients have been found to exhibit a 
tendency to the early acceptance of hypotheses formed in this task based on much 
more limited evidence than controls. This style of reasoning has been suggested to 
favour the formation of abnormal inferences, ultimately leading to the adoption of 
abnormal beliefs (Fine et al., 2007). In this study, we hypothesised that similar 
reasoning abnormalities might be present in patients with FMD which would favour 
formation of abnormal inferences about the sensory data arising during the 
physical event and could contribute to the development of functional symptoms. 
5.2 Methods 
5.2.1 Participants 
Eighteen patients with FMD were recruited by two methods: 
1. They were recruited from a pre-existing database of patients with 
movement disorders who had previously given the consent for their medical 
data to be stored in the ION Queen Square (Movement disorders Research 
Database) and to be contacted regarding participation in research studies by 
doctors authorised by Professor Bhatia or Dr Mark Edwards. These patients 
were contacted by telephone and the specific study was discussed with 
them. If the patient expressed interest in participating, a formal letter with a 
full description of the study and stating the date and location of the 
experiment was sent.  
2. Patients were directly recruited from the General Movement Disorder clinic 
of Dr Mark Edwards or Professor Kailash Bhatia as well as from the 
specialised Functional Movement Disorder run by Dr Edwards, at the NHNN 
90 
 
Queen Square, London, UK. The specific study was personally explained in 
detail and if the patient expressed interest in participating, a formal letter 
with a full description of the study and stating the date and location of the 
experiment was sent.  
I used as inclusion criteria: 
1. Age over 18 years.  
2. Diagnosis of clinically established or documented functional movement 
disorders according to Fahn and Williams criteria (Fahn and Williams, 1988).  
I used as exclusion criteria: 
1. Age less than 18. 
2. Unable to communicate with researcher (e.g. does not speak English).  
Eighteen healthy subjects who were matched by age and gender were also 
recruited from a departmental register of volunteers and patient’s relatives.  
5.2.2 Design and measures 
5.2.2.1 Bead task 
The reasoning task was similar to previous designs (Garety et al., 1991). Participants 
were presented with two jars each containing 100 beads: Jar A with 85 red and 15 
blue beads and Jar B with 85 blue and 15 red beads. Both jars were then hidden 
from view. Participants were told that the experimenter would choose one jar and 
draw beads one at a time from this jar. Beads would be replaced in the jar after 
each draw.  
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Two conditions were performed in the same order in each participant. In condition 
1 (Figure 5.1), “draws to decision” methodology was employed. Here, participants 
requested as many beads as they deemed necessary to decide from which jar the 
beads were being drawn. Beads (red: R; blue: B) were presented in the following 
sequence: RRRBRRRRRBBRRRRRRRRB. After each draw, participants were asked if 
they were certain which jar had been chosen. Participants were told that they were 
allowed as many trials as they needed to be completely sure. The dependent 
variable was the number of draws taken to reach a decision (draws to decision). We 
classified as “extreme responding” participants who required two or fewer draws 
before making a decision (Garety et al., 1991). 
 
Figire 5.1. Schematic representation of the jars and the sequence used to drawn the 
beads in condition 1.  
 
In condition 2 (Figure 5.2), “draws to certainty” methodology was used to assess 
the response to confirmatory or contradictory evidence. All participants saw the 
same 20 beads sequence: RRRBRRRRBRBBBRBBBBRB. After each draw, participants 
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were asked to indicate their estimates of the likelihood of Jar A or Jar B having been 
chosen by placing a mobile pointer along a scale. The first 10 trials supported the 
hypothesis that beads were being drawn from Jar A (predominantly red beads), but 
the final 10 beads were inconsistent with this hypothesis. In this condition the trial 
continued for 20 draws for all participants. The dependent variables were: 1) effect 
of confirmatory evidence: the estimate given after the second bead (red) was 
drawn minus the estimate given after first bead (red) was drawn; 2) effect of 
disconfirmatory evidence: the estimate given after the third bead (red) was drawn 
minus the estimate given  after fourth bead (blue) was drawn (positive values 
indicate reduction in confidence); and 3) final decision after the last draw with 
respect to the probability that Jar A had been chosen. 
 
Figre 5.2. Schematic representation of the jars and the sequence used to drawn beads 
in condition 2.  
 
  
 
  
Support Jar A hypothesis Support Jar B hypothesis 
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5.2.2.2 Questionnaires 
5.2.2.2.1 Intelligence level 
To estimate the intelligence level of participants, we used the 12 items short form 
of Raven's Progressive Matrices test (Raven JC, 1977). This is a classic test of 
abstract or non-verbal reasoning in which a variety of figures, relationships and 
transformations are presented and the person must select the best of multiple 
choice alternatives to fill the empty corner (Figure 5.3). 
 
 
 
 
 
 
 
 
Figure 5.3. Example of one of the items used in the short version of the Raven’s 
Progressive Matrices. 
 
I used this test because many of the participants of this study were non-native 
English speakers and therefore we thought that a test avoiding verbal intelligence 
would be more appropriate.    
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5.2.2.2.2 Delusional ideation 
Delusional patients have been found to have the “jumping to conclusion” bias and 
therefore delusional ideation was assessed in our participants. We used the Peters 
et al. Delusions Inventory (PDI-21) which has been designed to assess delusional 
ideation in general population (Peters et al., 2004). It includes 21 questions asking 
whether or not the participant has a particular idea, incorporating measures of the 
distress, preoccupation and conviction associated with delusional beliefs. For each 
question participants answer yes/no and 1 point is assigned to each "yes" answer 
and a 0 to each "no" answer. Therefore, the possible range of scores was 0 to 21. 
The distress, preoccupation, and conviction ratings ranged from 0 to 5 for each 
item. A "no" answer automatically scored 0 on each of the three dimensions. A 
rating between 1 and 5 was obtained if the item had been answered "yes”. Total 
score of the questionnaire range from 0 to 336.  Higher scores indicate higher 
delusional ideation. 
5.2.2.2.3 Mood 
Some authors have suggested that mood disturbances may influence results in this 
cognitive task (Garety et al., 2005). Therefore participants completed the Hospital 
Anxiety and Depression rating scale (HADS) (Zigmond and Snaith, 1983) with 
reference to their mood the week prior to testing, which has been already 
explained in the previous chapter.  
5.2.3 Statistical analyses 
I used PASW statistical package (version 18) for statistical analysis. P values 
reported for categorical variables were calculated with the use of Fisher’s Exact 
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Test. Mann-Whitney U test was used to compare differences for numerical 
variables between groups. In order to determine the independent contribution of 
Raven’s matrices scores, delusional ideation, and anxiety and depression subscales 
of the HADS to bead task performance, a simple linear regression analysis was first 
performed. Those variables which were contributing factors to the results of the 
task in this analysis were entered en bloc as independent variables in a subsequent 
multiple linear regression analysis. A two-tailed α level of 0.05 was used as the 
criterion for significance in all analyses. 
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5.3 Results 
Baseline clinical and demographic features of the participants are given in Table 5.1. 
 
Table 5.1. Clinical and demographic characteristics of patients in the bead task 
 FMD (n=18) Controls (n=18) P-value 
Age (years) 
      Mean ± SD 
 
43.5 ± 12 
 
48.2 ± 14 
 
0.33 
Female / Male 12 / 6 10 / 8 0.73 
Disease duration (years) 
      Mean ± SD 
 
5.4 ± 4.5 
 
– 
 
– 
Type of FMD, n (%) 
     Tremor 
     Dystonia 
     Myoclonus 
 
12 (67) 
5 (28) 
1 (5) 
 
– 
– 
– 
 
– 
– 
– 
Treatment, n (%) 
     SSRIs 
     Benzodiazepines 
     None 
 
4 (22) 
2 (11) 
12 (67) 
 
– 
– 
– 
 
– 
– 
– 
Raven’s Matrices score 
       Mean ± SD 
 
7.6 ± 2.3 
 
8.7 ± 2.7 
 
0.13 
PDI-21 total score 
       Mean ± SD 
 
35.7 ± 32.9 
 
18.9 ±  21.2 
 
0.34 
HADS score,  mean ± SD 
      Anxiety subscale 
      Depression subscale 
      Total 
 
11.0 ± 3.9 
9.2 ± 4.2 
20.2 ± 7.3 
 
5.6 ± 3.4 
3.0 ±1.8 
8.1 ± 4.2 
 
0.001 
< 0.001 
< 0.001 
FMD = functional movement disorder; SD = standard deviation 
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In condition 1, a significant difference between groups was found for draws to 
decision: patients requested significantly fewer draws before making a decision 
than controls (U=33.50, z=-4.21, p<0.001) (Figure 5.4 and Table 5.2). Seven patients 
(40%) but no control participants met criteria for “extreme responding”.  
In condition 2 (Table 5.2), a significant difference between groups was found when 
confronted with potentially disconfirmatory evidence: patients had significantly 
greater reduction in confidence, whereas controls were more likely to make no 
change or to continue to affirm their initial hypothesis by increasing their degree of 
certainty (U=94.5, z=-2.28, p=0.02). There were no significant differences between 
groups regarding the effect of confirmatory evidence. Ten patients and only three 
controls chose Jar B as their final decision (p=0.03). 
 
 
 
 
 
 
 
 
 
Figure 5.4. Results of functional patients and healthy controls in condition 1 of the 
bead task. 
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Table 5.2. Results in condition 1 and condition 2 of the bead task 
 FMD (n=18) Controls (n=18) P value 
Draws to decision 
Mean ± SD 
 
2.5 ± 1.2 
 
5.56 ± 2.0 
 
< 0.001 
Effect of confirmatory evidence
*
 
Mean ± SD 
 
0.5 ± 15.4 
 
5.5 ± 2.2 
 
0.32 
Effect of disconfirmatory evidence
†
 
Mean ± SD 
 
4.8 ± 33.2 
 
-2.6 ± 5.4 
 
0.02 
Final decision (Jar B chosen)  
n (%) 
 
10 (56) 
 
3 (17) 
 
0.03 
*Effect of confirmatory evidence: the estimate given after the second bead (red) was drawn minus the estimate given after 
first bead (red) was drawn; positive values indicate an increase in confidence.  
†Effect of disconfirmatory evidence: the estimate given after the third bead (red) was drawn minus the estimate given after 
fourth bead (blue) was drawn; positive values indicate a reduction in confidence. 
FMD = functional movement disorder; HADS = Hospital Anxiety and Depression Scale; SD = Standard Deviation; SSRIs = 
selective serotonin reuptake inhibitors. 
 
There were no significant differences between groups in Raven’s matrices scores 
(U=87.0, z=-1.50, p=0.13) or PDI-21 scores (U=74.0, z=-0.79, p=0.43) (see Table 5.1). 
Patients scored significantly higher than controls on anxiety and depression subscales 
of the HADS (U=52.5, z=-3.47, p<0.001; U=30.0, z=-4.2, p<0.001; respectively). We 
assessed whether Raven’s matrices, PDI-21, anxiety and depression scores were 
individual predictors of the reasoning performance. In the simple linear regression 
analysis, only anxiety and depression scores were contributing factors to draws to 
decision (R2=0.22, p=0.004; R2=0.27, p=0.001; respectively). Since anxiety and 
depression scores were significantly higher in patients than in controls, we 
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investigated in more detail whether belonging to one group or the other was a 
potential confounder factor. When both anxiety and depression scores were 
considered in a multiple linear regression analysis and their contribution was adjusted 
in a second step by group as a possible confounder neither anxiety nor depression 
scores were predictive factors to draws to decision (β= −0.06, p=0.73; β= −0.036, 
p=0.87; respectively). 
5.4 Discussion 
In this study we assessed probabilistic reasoning in patients with FMD using the 
bead task, a classic paradigm in psychiatry research for the study of belief 
formation under conditions of uncertainty (Garety et al., 1991, Fine et al., 2007). 
We found differences in probabilistic reasoning between patients with FMD and 
healthy participants. First, patients required less evidence before making a definite 
decision on the task. Second, patients integrated new, potentially discomfirmatory 
evidence into their decision making differently than controls. They were more likely 
to make changes in their probability estimates in the direction suggested by the 
new evidence, and to make a final decision consistent with this new evidence. Both 
aspects of the bead task are conceptually related to frontal lobe functions such as 
set shifting and impulsivity, and similar abnormalities have been found in delusional 
patients. These data appear not to be influenced by the higher levels of depression 
and anxiety found in the patient group.  
How might these preliminary data help to inform our understanding of the 
underlying mechanism of symptom production in FMD? This experiment was 
prompted by the association between physical triggering events and the production 
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of phenomenologically related symptoms in patients with functional neurological 
disorders. The process of making inferences on the causes of sensory data and 
incorporating these into an internal model of the world is central to a modern 
Bayesian approach to understanding the brain (Friston, 2010). Impulsivity in 
decision-making may reflect an abnormal overweighting of the importance of 
sensory data which causes an inappropriate updating of internal models relating to 
the data. Extrapolating such a reasoning style to sensory data occurring during a 
physical triggering event, this might produce inappropriate updating of 
expectations regarding future sensory data, for example an expectation of pain, 
abnormal movement or weakness, which might drive future physical symptoms. 
This initial formulation, although speculative, could form the basis of a testable 
biopsychosocial framework for FMD.  
Patients were more likely to respond to potentially disconfirmatory evidence by 
changing their probability decision in the direction of the new evidence, seemingly 
at odds with the fixity with which illness beliefs are sustained by this patients group. 
Indeed, a similar question has been raised by those studying delusions. Here the 
suggestion has been, supported by experimental evidence, that over time beliefs 
shift from a more flexible “goal-directed” ventral corticostriatal system to a more 
inflexible “habit-related” dorsal striatal system (Corlett et al., 2010). If this is also 
relevant to functional disorders, then the period of time following the initial 
triggering event must be important in creating persistence and fixity of abnormal 
beliefs. This would be consistent with the, negative correlation between time to 
diagnosis and chance of recovery previously found in functional disorders (Wyllie et 
al., 1990) and the fact that, at least in the early stages, simply explaining the 
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diagnosis can lead to long-term resolution of symptoms (Hall-Patch et al., 2010). In 
contrast, fixity of illness belief is associated with poor long-term outcome 
(Buchanan and Snars, 1993). Though we highlight the similarity of performance of 
patients with FMD on this task and previous studies of patients with delusions, the 
lack of difference between FMD patients and controls in the PDI-21 inventory 
indicates that patients with FMD are not suffering generally from delusional beliefs.  
Limitations 
We acknowledge limitations to our study. First, the sample size is small and we 
cannot exclude that in a larger cohort data may be different. However, we chose 
patients with clinically typical FMD using standardized criteria and feel that they do 
accurately represent patients with these diagnoses. Second, FMD patients tend to 
have concomitant mood abnormalities as measured by HADS. However, multiple 
regression analysis revealed that anxiety and depression scores were not 
independent predictors of the draws to decision. This is in line with several reports 
which have failed to find an, association between performance on the bead task 
and mood disturbance. Future studies could nevertheless compare the cognitive 
style of FMD patients with depressed and anxious patients without FMD. Third, 
while we have controlled for the presence of delusions in general, we have not 
measured other psychiatric comorbidities such as personality disorder that could be 
confounding the results. 
In conclusion, we present preliminary evidence of a “‘jumping to conclusions” style 
of cognitive reasoning in patients with FMD. These data may have relevance to the 
manner with which patients with functional symptoms process novel sensory data 
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occurring during physical triggering events commonly reported at onset of 
symptoms. 
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Chapter 6: A study on the effect of explicit strategies 
and predictability on motor control in functional 
movement disorders 
The work presented in this chapter was originally published in the form of a research article: 
Pareés I, Kassavetis P, Saifee TA, Sadnicka A, Davare M, Bhatia KP, Rothwell JC, Bestmann S, 
Edwards MJ. Failure of explicit movement control in patients with functional motor 
symptoms. Movement Disorders 2013; 28: 517-23. 
6.1 Introduction 
I emphasized in Chapter 3 that one of the aims of this thesis is to better understand 
mechanism of symptom production and that I have taken as the starting point the 
manner in which the diagnosis of FMD is made in neurological practice.  
In this regard, the clinical basis for making a positive diagnosis in this group of 
patients is quite clear: movement becomes normal when attention is diverted away 
from the movement, or when movement is triggered covertly. This typically occurs 
during implicit motor control which is engaged in ‘automatic’ movements where 
attentional processes have limited contribution. In contrast, motor impairments are 
manifest only during periods of explicit attention to movement. Therefore, it would 
seem a priori that an understanding of the mechanism underlying these robust 
clinical phenomena would be essential to explain symptom generation in patients 
with FMD. However, these apparently simple clinical tests are in fact complex tasks 
when viewed from an experimental perspective, and at the present time it is not 
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clear which aspects of movement control might be important in generating 
impairment.  
Taking all these considerations into account, I decided to investigate the distinction 
between implicit and explicit motor control in patients with FMD. Two different 
experiments were designed in which voluntary movements were made either with 
an opportunity for explicit awareness/control, or were performed in a largely 
implicit fashion. We hypothesized that, even within the same limb, implicit 
influences on movement would be preserved whereas explicit control would be 
abnormal in patients with FMD. 
6.2 Methods 
6.2.1 Participants 
Eleven patients were directly recruited from the General Movement Disorder clinic 
of Dr Mark Edwards or Professor Kailash Bhatia as well as from the specialised 
Functional Movement Disorder run by Dr Edwards, at the NHNN Queen Square, 
London, UK. The specific study was personally explained in detail and if the patient 
expressed interest in participating, a formal letter with a full description of the 
study and stating the date and location of the experiment was sent.  
I used as inclusion criteria: 
1. Age over 18 years.  
2. Diagnosis of clinically established or documented FMD according to Fahn 
and Williams criteria (Fahn and Williams, 1988).  
I used as exclusion criteria: 
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1. Age less than 18. 
2. Unable to communicate with researcher (e.g. does not speak English).  
The control group consisted of 11 healthy participants matched with respect to 
gender, age, and handedness. 
Demographic and clinical details, including HADs (Zigmond and Snaith, 1983), are 
shown in Table 6.1. 
 
Table 6.1. Baseline characteristics of patients with functional movement disorders in 
experiments 1 and 2 of the motor learning tasks 
Patient Gender Age (y) Handedness Diagnosis DD (y) HADs OB ROT Pre-cued task 
1 F 43 R 
Tremor 
(R hand) 
4 22 + + + 
2 F 30 R 
Tremor 
(R hand) 
1 13 + + + 
3 M 39 R 
Tremor 
(R hand) 
18 19 + + + 
4 F 61 R 
Tremor 
(R hand) 
4 29 + + + 
5 M 52 L 
Tremor 
(L hand) 
9 12 + + + 
6 F 26 R 
Paroxysmal 
ballism (arms) 
4 8 + + + 
7 M 41 R 
Tremor 
(R hand) 
3 27 + + + 
8 F 50 R 
Tremor 
(R hand) 
1 20 + + + 
9 F 18 R 
Dystonia 
(generalized) 
1 24 + + + 
10 M 64 R 
Tremor 
(R hand) 
12 27 + +  
11 M 42 R 
Tremor 
(R hand) 
5 20   + 
F = female; M = male; R = right; L = left; DD = disease duration; HADs = Hospital Anxiety and Depression Scale total score; OB = 
one-back reaching task; ROT = rotation learning task. + = participation in the experiment 
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6.2.2 Experimental Procedure 
6.2.2.1 Experiment 1: one-back reaching and rotation learning tasks 
Participants sat in front of a 17 inch computer monitor (refresh rate 50Hz, distance 
from subject to screen 45cm). A joystick was placed in front of them. The monitor 
displayed eight targets arranged in a circle with a radius of 13cm at intervals of 45⁰. 
A similar square target marked the centre of the circle, and a small yellow circular 
cursor indicated the joystick position. The experiment was programmed within 
MatLab version 7.0.1 with the Cogent Toolbox (http://www.vislab.ucl.ac.uk 
/cogent.php). 
In the baseline condition, 4 blocks of 40 trials were presented. At the start of each 
trial, the target to be aimed for turned red, and participants were instructed to 
move the joystick so that the yellow cursor was inside the target square (Figure 
6.1). Once the cursor was kept within the target square for 1 second, the target 
changed colour from red to green, and participants were instructed to move the 
joystick back to the centre square to start the next trial. Targets were always visible 
and presented in a random pattern in each block. Participants were instructed to 
move to the target as quickly as possible. Temporal and spatial variables used to 
characterize task performance were reaction time (RT: time in ms from target 
presentation to movement onset), movement time (MT: time in ms from 
movement onset to stabilisation of the cursor in the target), and displacement ratio 
(DR: ratio between the length –measured in pixels– of a straight line “perfect path” 
between the starting point and the target, and the length of the actual path taken 
by the participant, with higher values of DR indicating increasing deviation from the 
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perfect path). Participants then performed in a randomised order a one-back 
reaching task (OB), or a rotation learning task (ROT). 
 
Figire 6.1. Schematic representation of the three conditions of experiment 1. 
 
In the OB task, explicit motor control was tested (Mazzoni and Wexler, 2009). 
Participants were instructed to move the cursor to the target displayed in the 
previous trial (Figure 6.1). One block of 40 trials was performed. Targets were 
presented in a random pattern during the block. Improvement in motor 
performance during the task was defined as the ratio of each of the temporal and 
spatial variables in the first ten trials and the last ten trials. A ratio of < 1 for RT, MT 
and DR variables indicated improvement. Target selection errors, the number of 
which would reflect working memory performance required to perform the task 
(Mazzoni and Wexler, 2009), was monitored by using directional error. This was 
defined as the difference (in degrees) between the cursor direction and the target 
direction at peak velocity. Based on previous research, we set the size of the range 
outside of which directional error was assumed to represent incorrect target 
selection as ±6times the standard deviation of the directional error in the baseline 
condition (Mazzoni and Wexler, 2009). 
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In the ROT task, implicit motor control was tested (Mazzoni and Wexler, 2009). This 
task measured the ability of participants to adapt to a visuomotor perturbation. A 
constant 30⁰ anticlockwise rotation was introduced into the path of the cursor 
displayed on the screen (Figure 6.1). Targets were displayed in a randomised order, 
and participants had to move the cursor to the highlighted target as quickly as 
possible. Participants were not instructed how to compensate for the rotation. 
Improvement would be indicated by a ratio in the first ten trials and the last ten 
trials of < 1 for RT, MT and DR. 
6.2.2.2 Experiment 2: pre-cued choice reaction time with varying cue 
validity 
In this experiment we manipulated the predictability of an upcoming movement 
(Bestmann et al., 2008). Participants sat in front of a 17 inch computer monitor 
(refresh rate 50Hz, distance from subject to screen 45cm). A standard QWERTY 
computer keyboard was placed in front of them. Their left index finger was placed 
over the "Z" key and the right index finger was placed over the "M" key. 
In a training session, participants were required to respond with one or other key to 
the presentation of two different symbols. They were told that “Z” was associated 
with one symbol, and “M” with the other. Feedback was given on the accuracy of 
their choice, and 40 trials were conducted. This ensured accurate response 
mapping of keypress to symbol, with all subjects achieving a 100% correct response 
level by the end of training. 
There were three experimental conditions each performed twice in a randomised 
order across participants. Each trial started with a fixation cross in the centre of the 
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screen, followed 450ms later by presentation of the preparation cue for 200ms: 
one of the two symbols seen in the practice session coloured white. The fixation 
cross was then displayed for a fixed delay period of 1500ms. Finally, the "go" cue 
was displayed, which was one of the two symbols from the practice session 
coloured green (Figure 6.2). Participants were instructed to press the key 
corresponding to the go cue as quickly as possible. Each condition consisted of 80 
trials. No feedback was given. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2. Schematic representation of experiment 2 (Pre-cued Choice Reaction Time 
with Varying Cue Validity). 
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In the 50% validity condition (50v), the preparation cue accurately predicted the 
"go" cue in 50% of trials, i.e. it had no predictive value. In the 75% validity (75v) and 
the 95% validity (95v) conditions, the preparation cue accurately predicted the "go" 
cue in 75% and 95% of trials, respectively. 
We calculated response time in ms (time from presentation of the "go" cue to key 
press) for each trial. Trials where the preparation cue accurately predicted the "go" 
cue (valid trials) were separated from those where the prediction was incorrect 
(invalid trials). We then averaged response times for valid and invalid trials 
separately across all trials performed for each of the three conditions. We expected 
that response times for valid trials would become shorter for conditions with 
increasing validity of the preparation cue.  
6.2.3 Statistical analysis 
We used the PASW statistical package (version 18). P values for categorical 
variables were calculated with Fisher’s Exact T. Kolmogorov-Smirnov test was used 
to assess the normal distribution of the data. Analysis of variance (ANOVA) was 
used to compare differences in means for numerical data when parametric 
assumptions were met. Post-hoc T-tests with Bonferroni corrections were used. 
When data were not normally distributed, non-parametric tests (Mann-Whitney U 
test, Friedman ANOVA, Wilcoxon test and Spearman correlation) were used. 
Statistical significance of p<0.05 was assumed. 
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6.3 Results 
6.3.1 Experiment 1: one-back reaching and rotation learning tasks 
Ten patients and ten healthy controls participated. All patients performed the 
experiments with the affected (dominant) hand except for one patient who was 
unable to adequately control the joystick because of the severity of the tremor 
affecting the dominant hand. The results of this patient did not differ systematically 
from the others. All controls used their dominant hand. Exploration of the data 
revealed them to be not normally distributed, and therefore non-parametric tests 
were used.  
6.3.1.1 Baseline Performance 
Patients with FMD had a significant change over the four blocks of the baseline 
condition in MT (χ2 (3)=17.16, p<0.001) and in DR (χ2 (3)=18.84, p<0.001). Post hoc 
analysis using Wilcoxon tests showed improvement in performance from Block 1 to 
Block 4 for MT (median Block 1=1695.5ms, median Block 4=1363.7ms; Z= -2.8, 
p=0.002) and for DR (median Block 1=5.45, median Block 4=4.57; Z= -2.8, p=0.002). 
There was no difference in these parameters between Block 3 and 4, indicating a 
ceiling effect in baseline motor performance. In the control group, there was a 
trend for improvement in performance across the 4 blocks. Comparison of temporal 
and spatial variables in Block 4 of the baseline condition between patients and 
control participants revealed that there was no difference in RT between groups 
(323.9ms vs 286.5ms; U=24.0, Z= -1.07, p=0.32) but the patients were slower in MT 
(1363.7ms vs 1036.3ms; U=24.0, Z= -2.34, p=0.02) and had poorer accuracy 
measured as DR (4.57 vs 3.48; U=8.0, Z= -2.64, p=0.003). 
112 
 
6.3.1.1.1 One-Back Reaching 
Patients and control participants differed in performance in the OB condition. Both 
patients and controls had a similar improvement in RT and DR between the first and 
the last ten trials (U=32.0, Z= -1.36, p=0.18 and U=39.0, Z= -0.83, p=0.42, 
respectively). However, while MT also improved in control participants, it did not in 
patients and a ratio of MT in first ten and last ten trials was greater than 1, 
indicating a deterioration in performance over the course of the block (U=38.0, Z= -
2.19, p=0.03). Results of ratios are shown in Table 6.2 and illustrated in Figure 6.3. 
There was no difference between number of target selection errors seen in patients 
and control participants (U=29.5, Z= -1.64, p=0.12).  
6.3.1.1.2 Rotation Learning 
In the ROT condition both groups improved their performance across the block 
when comparing the results of the temporal and spatial variables in the first 10 and 
last 10 trials: RT (χ2 (1) =5.0, p=0.041); MT (χ2 (1)=7.2, p=0.012) and DR (χ2 (1)=9.8, 
p=0.003). The amount of improvement in each variable, measured as the ratio of 
the first 10 and last 10 trials, did not differ between groups. Results of ratios are 
shown in Table 6.2 and illustrated in Figure 6.3. 
Spearman correlation coefficient revealed no association between HADs scores and 
target selection errors or temporal or spatial variables in patients or healthy 
controls in either task. 
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Table 6.2. One-Back Reaching and Rotation Learning Tasks Results 
 Patients with FMD Healthy controls P value 
OB (explicit motor control); ratio (median) 
     Reaction time 0.96 0.81 0.18 
     Movement time 1.10 0.78 0.03 
     Displacement ratio 0.95 0.90 0.42 
ROT (implicit motor control); ratio (median) 
     Reaction time 0.87 0.91 0.39 
     Movement time 0.91 0.82 0.32 
     Displacement ratio 0.84 0.77 0.28 
FMD = Functional movement disorder    
 
 
 
 
 
 
 
 
 
Figure 6.3. Results of Experiment 1. Boxplot presenting ratios between the first ten 
trials and the last ten trials of the temporal and spatial variables for patients with 
functional movement disorders and controls (A: One-back Reaching task and B: 
Rotation learning task). Improvement in motor control is indicated by a ratio <1. Thick 
black lines represent medians. Box edges represent the upper and lower quartiles. The 
whiskers represent the minimum and maximum values.*p<0.05 
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6.3.2 Experiment 2: pre-cued choice reaction time with variable 
cue validity 
Ten patients and ten healthy controls participated in this experiment. We first 
performed an ANOVA with PROBABILITY (0.5, 0.75, 0.95) and VALIDITY 
(Valid/Invalid cue) as main factors, and with GROUP (Patients, Controls) as a 
between subjects factor. This revealed a PROBABILITY x VALIDITY x GROUP 
interaction (F(2,17)=12.2; p=0.001). We explored this interaction with separate 
ANOVAs on the data in each of the three conditions (50v, 75v, 95v) with VALIDITY 
(valid cue, invalid cue) as main factor and GROUP (patients, controls) as a between 
subjects factor. In the 50v condition, there was no effect of validity (p=0.39), nor a 
Group x Validity interaction (p=0.36). In the 75v condition there was an effect of 
validity (F(1,18)=32.7; p<0.0001) due to faster response times to valid cues 
compared with invalid cues. There was, however, no GROUP x VALIDITY interaction 
(p=0.14). In the 95v condition, there was no effect of VALIDITY (p=0.51), but there 
was a GROUP x VALIDITY interaction (F(1,18)=18.8; p<0.0001). Exploration of this 
effect with post-hoc tests with Bonferroni corrections revealed this to be due to a 
faster response time for valid cues compared with invalid cues in controls (t=-4.5; 
p=0.001), but slower response time for valid compared with invalid cues in patients 
(t=2.2; p=0.05) (response time ratios between valid and invalid cues for each 
validity condition are shown in Figure 6.4). There were no differences in the 
number of errors made (incorrect key presses) between patients and controls.  
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Figure 6.4. Results of experiment 2. Ratios of the response time (ms) for valid/invalid 
cues in each validity condition. Ratio < 1 indicates faster response time for valid cues 
compared with invalid cues. Ration >1 indicates slower response time for valid cues 
compared with invalid cues. *p<0.05 
 
6.4 Discussion 
These experiments aimed to dissect experimentally the basis of the clinical 
examination techniques used to make a positive diagnosis of FMD by examining 
how motor performance is affected when automaticity of movement changes. I 
found that performance in FMD was specifically impaired in situations where 
movements were highly predictable and there was opportunity for explicit control. 
In the OB task, which explores explicit movement control under conditions of 
maximal certainty about the movement required, performance of patients was 
impaired: although they had a similar improvement in RT and DR compared to 
controls, there was a clear deterioration in the execution of the movement 
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measured as MT over the course of the block. Patients did not make more errors in 
target selection compared with controls, suggesting poor performance was not due 
to problems in the working memory requirement of the task. In contrast, 
performance was similar to healthy subjects in the rotation learning task which 
tests implicit motor performance.  
Likewise, when I manipulated the predictability of an upcoming movement by 
changing the validity of a pre-cue in a pre-cued reaction time task, patients had a 
paradoxical slowing of response times to valid cues when they were highly 
predictive of the movement required, despite normal performance in conditions 
where cues were non-predictive or 75% predictive.  
I have therefore demonstrated that under conditions of increasing certainty 
regarding the movement to be performed, and crucially when the nature of the 
task is one where pre-planning of movement can occur, impairment is seen in 
patients. This is supported by previous work in functional paralysis where impaired 
reaction time was seen after pre-cuing by a consciously perceived “endogenous” 
cue, but a normal response to a non-consciously perceived “exogenous” cue 
(Roelofs et al., 2003). The same group has reported increased N2 event-related 
potential amplitude during an explicitly-cued movement task, interpreted as 
reflecting enhanced “action monitoring” (Roelofs et al., 2006).  
My results fit within a body of research which has explored the effect of explicit 
strategies in motor control (Fourneret and Jeannerod, 1998).  Healthy people do 
not pay much attention to many aspects of their actions and normal movement is 
associated with a remarkable lack of activity in brain areas that correspond to high-
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level executive control (Jueptner et al., 1997). During motor learning, prefrontal 
and anterior cingulate activity that is present early in the task disappears with 
increasing movement automaticity. If over-trained subjects are then asked to 
attend to their actions, prefrontal activity and anterior cingulate activity returns, 
and there is deterioration in performance (Jueptner et al., 1997). Factors that have 
previously been reported to favour a shift to attentive manner of movement 
control include those associated with risk of development of functional symptoms, 
such as injury, physical illness, anxiety, depression and childhood trauma (Woody, 
1996, Orrell et al., 2009, Edwards and Rothwell, 2011). 
I suggest that a shift from a normal procedural mode of movement to an attentive 
self-focused action monitoring mode may occur in patients with FMD, which could 
impair movement kinematics in a similar fashion to that reported in sportspeople 
“choking” under pressure (Beilock and Carr, 2001). Such a shift would only be 
possible during preparation for movement that was highly predictable and 
accessible to pre-planning. This would explain my data showing no impairment 
where movement parameters were likely governed by implicit processes or when 
movement was not highly predictable. This explanation would be consistent with 
resolution of functional motor symptoms when attention is distracted away 
revealing an intact procedural memory for movement.  
I acknowledge several limitations to these studies. We have studied a small cohort 
of patients, and we cannot exclude that in a larger cohort data may be different. I 
have interpreted the findings with reference to ideas of explicit versus automatic 
(implicit) control of movement. These are well-researched topics within motor 
118 
 
control, but I also accept that they are not precisely defined. I have speculated that 
increasing predictability of a required movement allows opportunity for explicit 
control, but we are not able to measure it within this experimental framework, and 
therefore this remains a speculative interpretation. I did not compare patients with 
FMD and patients affected by “organic” movement disorders. It might be argued 
that they can also develop an abnormal awareness of movement which could 
specifically interfere with explicit motor control and with movements that are 
predictable. However, previous studies in patients with well recognized “organic” 
disorders such as Huntington’s disease and PD have reported abnormalities in both 
explicit and implicit motor learning tasks (Ghilardi et al., 2003, Siegert et al., 2006, 
Wilkinson and Jahanshahi, 2007, Ghilardi et al., 2008). Also, patients with PD have 
been found to show similar improvements in RT as healthy controls in the context 
of highly predictable events (Galea et al., 2012). Patients did not make more errors 
in target selection compared with controls in the OB task, and I suggested that poor 
performance here was not due to impairments in working memory. However, 
formal assessment of working memory was not performed in these patients and we 
acknowledge this would have been appropriate. Finally, I did not compare our 
results with people feigning symptoms. However, previous work in volunteers 
feigning found them to be poor at moving “slightly” slow: movements were often 
performed with long delays (at least 500ms in duration) (Willison and Tombaugh, 
2006, Reicker, 2008). In contrast, the impairments in movement and response 
times in our patients were small (of the order of 50-100ms), and in our view not 
likely to be consistent with malingered poor performance. 
Conclusions 
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These data demonstrate that movement impairment in patients with FMD is 
restricted to tasks where the predictability of movement is high and is therefore 
accessible to pre-planning, and not where movement is unpredictable or where 
movement occurs in an implicit fashion. This suggests that a shift to a conscious 
attentive control of may play a relevant role in symptom generation. 
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Chapter 7: A study assessing functional motor 
symptoms in real life conditions using a wrist-worn 
actigraph 
This is a pre-copyedited, author-produced PDF of an article accepted for publication in Brain 
following peer review. The version of record [Pareés I, Saifee TA, Kassavetis P, Kojovic M, 
Rubio-Agusti I, Rothwell JC, Bhatia KP, Edwards MJ.Believing is perceiving: mismatch 
between self-report and actigraphy in psychogenic tremor. Brain. 2012 Jan; 135(Pt 1):117-
23] is available online at: http://brain.oxfordjournals.org/content/135/1/117.long. 
7.1 Introduction 
In the previous chapter, I explored (in an experimental setting) the role of explicit 
strategies in motor control in FMD. I demonstrated that the motor impairment seen 
in these patients seems to be restricted to tasks where the movement is accessible 
to pre-planning, suggesting that a shift to a conscious attentive control of 
movement may play a relevant role in symptoms generation. This fits with the 
findings during the clinical examination that the symptom improves or even 
disappears when attention is diverted away from the symptom.  
However, the reality reported by most patients in the clinic is different: they 
typically report abnormal movements to be present constantly often causing severe 
disability and affecting their day to day life.   
In this chapter, I describe the results of a study aimed to assess FMD, outside of the 
clinic, in real life conditions. I decided to study patients with FT, as this is the most 
common FMD, is relatively distractible and patients usually describe it as very 
disabling. I took advantage of the ability to assess the duration and intensity of 
121 
 
tremor accurately, remotely and for long periods of time using a wrist-worn 
actigraph device (Van Someren et al., 2006). In contrast to cumbersome devices 
used in the past for ambulatory tremor monitoring (Spieker et al., 1997, Spieker et 
al., 1998), this device is small and has been demonstrated to accurately 
differentiate tremor from other movements. We used this device in a cohort of 
patients with FT and patients with “organic” tremor (OrgT) in a natural setting over 
5 days, and we compared these data with self-report of tremor duration over the 
same period and a standardised face-to-face clinical assessment of tremor severity.  
7.2 Methods 
7.2.1 Participants  
I recruited 10 patients with FT from the Movement Disorder outpatient clinics run 
by Dr Edwards and Professor Bhatia at the NHNN, London, UK.  
Inclusion criteria were: 
1. Age over 18 years. 
2. Diagnosis of clinically established or documented FT according to Fahn and 
Williams criteria (Fahn and Williams, 1988). 
3. Tremor in at least one arm at rest, on posture or both of a moderate/severe 
level judged by a score of at least two on Part A of the Fahn-Tolosa-Marin 
(FTM) scale (Fahn S, 1988). 
Exclusion criteria were: 
1. Patients with any major concurrent neurological disorder 
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I also recruited eight patients with OrgT who served as a control group.  
Inclusion criteria were: 
1. Age over 18 years. 
2. Presence of clinically typical tremor and course of illness for their diagnosis. 
3. Moderate/severe tremor (at rest, on posture or both) in at least one arm 
judged by a score of at least two on Part A of the FTM scale (Fahn S, 1988).  
Exclusion criteria: 
1. Patients with marked clinical fluctuations in response to medication. 
The purpose of the study was explicitly explained to the participants. 
7.2.2 Questionnaires and scales 
7.2.2.1 Fahn-Tolosa-Marin scale for tremor (FMT) 
At the inclusion visit, tremor was rated using the FTM (Fahn S, 1988). This is a 
widely used clinical rating scale in which severity of tremor is rated by body part 
from 0 (none) to 4 (severe). It has three subscales: Part A assesses examiner-
reported tremor location and severity. In part B examiner reports the ability of the 
patient to perform specific motor tasks (writing, drawing, and pouring with 
dominant and non-dominant hands). Finally, in part C patient reports functional 
disabilities due to tremor (speaking, eating, drinking, hygiene, dressing, writing, 
working, and social activities). Participants were videotaped during clinical 
assessment.  
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7.2.2.2 Handedness 
Hand dominance was assessed by the Edinburgh Handedness Inventory (Oldfield, 
1971). This is a ten-item questionnaire in which individuals have to self-report the 
preferred hand for carrying out common activities such as writing and drawing, 
throwing, and using utensils such as a toothbrush, knife, and spoon. Individuals 
have to place 1 or 2 check marks under "left" or "right" to specify the strength of 
preference for each activity (2 checks indicate the largest preference: the individual 
"would never try to use the other hand unless absolutely forced to"). A laterality 
measure can be calculated where a score of 100 indicates complete dextrality, and 
a score of −100 indicates complete sinistrals. 
7.2.2.3 Quality of life 
EuroQol ED-5Q was used to assess quality of life (Brooks R, 2003). It assesses five 
dimensions of functioning and quality of life (mobility, self-care, usual activities, 
pain and anxiety and depression). All dimensions are divided into three levels 
reflecting ‘no problem’, ‘some problem’ and extreme problem’, with the focus of 
that dimension. EuroQoL ED-5Q also includes a 20 cm visual analogue scale as a 
means of valuing the participant’s health state. The end-points of the scale are 
labelled ‘best imaginable health state’ and ‘worse imaginable health state’ 
anchored at 100 and 0, respectively. Participants were asked to indicate how they 
rate their own health state by drawing a line from an anchor box to that point on 
the scale which best represents their own health. 
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7.2.2.4 Post-study questionnaire  
I designed a post-study questionnaire to assure that participants had understood 
the purpose of the study.  Patients were retrospectively contacted by telephone 
and were asked two questions: a) “What do you think was the purpose of wearing 
the watch?” and b) “For how much of the time that you were wearing the watch do 
you think it was turned on?”  
7.2.3 Tremor recording 
I used Actiwatch (Cambridge Technology, Cambridge UK) to objectively motorize 
tremor. The Actiwatch contains a uniaxial accelerometer consisting of a small mass 
fixed to a piezoceramic bar. When the piezoceramic bar is distorted by acceleration, 
a current is induced that is proportional to acceleration. The device continuously 
samples the output of this internal accelerometer at 64Hz, with an 8-bit resolution 
covering -5 to +5G. The algorithm programmed in the Actiwatch has been validated 
to discriminate tremor from other movements with high sensitivity and specificity 
(Van Someren et al., 2006). Continuous recording of duration and intensity of 
tremor for up to 22 days is possible. Optimal sensitivity is achieved for tremor of a 
frequency equal to or above 3 Hz. Tremor duration is reported by the Actiwatch 
software as seconds of tremor per minute of recording. Tremor intensity is 
reported as the highest amplitude of tremulous movement in each minute 
measured as counts (25 counts/second representing approximately an acceleration 
of 1G) (The Actiwatch User Manual, version 7.2; http:www.camntech.com). 
Participants were instructed to wear the actigraph on the wrist of the most 
tremulous arm constantly for five consecutive days. They were instructed that the 
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actigraph should only be taken off when the hands were exposed to water (e.g. 
showering or swimming). 
7.2.4 Diaries 
I designed a self-completed diary for the participants to subjectively rate their 
tremor for the same days as the actigraph was worn. This had five sheets, each 
sheet covering one day. On each sheet participants were asked to record the time 
of waking up and going to bed, as well as any time that they spent without wearing 
the actigraph. For three pre-defined intervals per day (time from waking to 1:00 
pm, from 1:00 pm to 7 pm, and time from 7:00 pm to bedtime) they were asked to 
mark the percentage of time they estimated themselves as having tremor on a 
visual analogue scale marked from 0 (no tremor) to 100 (tremor 100% of the time 
interval). I termed these ‘intra-day interval estimations’. I also asked participants to 
estimate on average the proportion of the whole waking day that they had 
experienced tremor by using the same type of visual scale. I termed this the ‘whole 
day period estimation’. Finally, I asked subjects to record whether they felt that the 
day had been typical for them in terms of the amount of tremor they experienced. 
7.2.5 Data analysis and statistics 
Duration of the waking day was defined as the time from waking up to bedtime 
minus the amount of time that each participant took the actigraph off in minutes. 
Duration of tremor was calculated as the total amount of seconds with tremor as 
measured by the actigraph during the waking day. The results were expressed both 
in minutes and as percentage of the duration of the waking day. To compare intra-
day interval estimations reported in the daily diary with the results of the actigraph, 
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I converted the amount of time with tremor measured by the actigraph to a 
percentage of each interval of time.  
We used the PASW statistical package (version 18) and MedCalc (version 11.6) for 
statistical analysis. P values for categorical variables were calculated with the use of 
Fisher’s Exact Test. T-Tests were used to compare differences in means for 
numerical data when parametric assumptions were met and Mann-Whitney U tests 
when data was not normally distributed. Statistical significance of p<0.05 was 
assumed. Bland-Altman analysis corrected for repeated measurements was used to 
assess the agreement between ‘intra-day interval estimations’ and tremor 
measured by actigraphy (Bland and Altman, 2007). Results are expressed as the 
mean bias (difference between tremor reported in diaries minus tremor recorded 
by actigraphy: positive values indicating overestimation in diaries, negative values 
indicating underestimation in diaries) and 95% confidence intervals. We plotted 
these against the geometric mean of the two measures (calculated by multiplying 
‘intra-day interval’ estimations and results from the actigraphy and taking the nth 
root, where n was the number of values to average), giving me an opportunity to 
assess bias when diary and actigraphy scores were at different levels. Intra-day 
interval estimations not clearly reported were excluded from this analysis. 
7.3 Results 
7.3.1 Baseline characteristics 
Eight patients with FT and 8 patients with OrgT completed the study. After initially 
agreeing to take part, two patients with FT decided not to complete the study. One 
reported severe pain in the affected arm meaning he could not wear the watch and 
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the other reported an allergic skin reaction due to the watch strap. In the OrgT 
group, five (62.5%) patients had PD, two (25%) had dystonic tremor and one 
(12.5%) had Wilson’s disease.  
Table 7.1 summarises the clinical and demographic data. 
 
Table 7.1. Baseline characteristics of patients    
 FT (n=8) OrgT (n=8) P value 
Age (years) 
     Mean (SD) 
 
52.3 (12.1) 
 
66.1 (14.1) 
 
0.054 
Sex, n (%) 
     Male 
     Female 
 
4 (50) 
4 (50) 
 
6 (75) 
2 (25) 
 
0.61 
  
Handedness, n (%) 
     Right 
     Left 
 
6 (75) 
2 (25) 
 
7 (88) 
1 (12) 
1.0 
Disease duration (years) 
     Mean (SD) 
 
10.7 (11.8) 
 
7.6 (4.7) 
 
0.92 
Triggering  event prior to onset of  tremor 
     Yes 
     No 
 
6 (75) 
2 (25) 
 
0 
8 (100) 
0.007 
Fahn-Tolosa-Marin tremor scale, mean (SD) 
     Subscale A 
     Subscale B 
     Subscale C 
     Total 
 
9.1 (3.7) 
9.5 (6.0) 
15.2 (4.4) 
34.0 (11.3) 
 
12.5 (7.8) 
10.6 (4.8) 
8.1 (5.4) 
31.1 (13.8) 
 
0.29 
0.69 
0.01 
0.66 
EQ-5D (dimensions), n (%)* 
     Mobility 
     Self-care 
     Usual activities 
     Pain 
     Anxiety/depression 
 
8 (100) 
8 (100) 
8 (100) 
7 (88.5) 
6 (75) 
 
3 (37.5) 
1 (12.5) 
5 (62.5) 
0 
2 (25) 
 
0.03 
0.001 
0.001 
0.2 
0.13 
EQ-5D visual analogue scale 
     Mean (SD) 
 
42.6 (22.0) 
 
75.4 (8.0) 
 
0.002 
Treatment for tremor, n (%) 
     No 
     Yes 
 
6 (75) 
2 (25) 
 
2 (25) 
6 (75) 
0.13 
Active compensation/litigation 0 0  
SD = Standard deviation 
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The OrgT group was slightly older than the FT group (66.1yrs vs. 52.3yrs; p=0.0054), 
but they were matched on tremor severity as judged by the FTM scale. Two (25%) 
functional patients and six (75%) “organic” patients had tremor elsewhere apart 
from the arm wearing the actigraph. FT patients rated their quality of life as 
significantly more impaired than OrgT patients. Two (25%) functional patients were 
receiving treatment for tremor at the time of the study (propranolol in both cases) 
whereas six (75%) “organic” patients were on treatment (antiparkinsonian drugs in 
five cases and propranolol in one). 
7.3.2 Comparison between actigraphy and self-report of tremor 
There were no differences between groups regarding their reported duration of the 
waking day and the amount of time they were not wearing the actigraph (Table 
7.2). 
 
Table 7.2. Results of the wrist-worn actigraph study 
 FT (n=8) OrgT (n=8) P value 
Waking day duration (minutes) 
     Mean (SD) 
 
860.8 (222.6) 
 
975.6 (47.3) 
 
0.93 
Time without the actigraph (minutes) 
     Mean (SD) 
 
36.2 (25.7) 
 
24.4 (21.4) 
 
0.42 
No of representative days* 
     Mean (SD) 
 
5 (0) 
 
4.4 (1.1) 
 
0.64 
Tremor intensity (counts/sec) 
     Mean (SD) 
 
13.6 (10.25) 
 
12.2 (5.84) 
 
0.83 
Waking day Tremor duration 
     Diary (%), mean (SD) 
     Actigraphy (%), mean (SD) 
     Actigraphy (minutes), mean (SD) 
 
83.5 (14.0) 
3.9 (3.7) 
31.1 (30.7) 
 
58.0 (19.8) 
24.8 (7.7) 
240.0 (70.1) 
 
0.01 
0.001 
0.001 
SD = Standard deviation    
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Patients with FT reported the five-day period of the study as 100% representative 
of a normal day in terms of tremor whereas patients with OrgT considered 87.5% of 
the five-day period as representative. None of the actigraphs ran out of power 
during the experiment. 
In diaries, ‘whole day period’ estimation for duration of tremor, as percentage of 
the waking day, was significantly higher in patients with FT than patients with OrgT 
(83.5% ±14.0 vs. 58.0% ±19, respectively; p<0.01). However, mean percentage of 
the waking day with tremor measured by actigraphy was significantly lower in the 
FT group (3.9% ±3.7; 31.1 ±30.7 minutes) compared with the OrgT group (24.8% 
±7.7; 240.0 ±70.1 minutes) (p=0.001). The mismatch between diary estimates and 
actigraphy measures is illustrated in Figure 7.1. When tremor was present, there 
was no difference between groups in the intensity of tremor measured by the 
actigraph (p=0.83). 
Since both patients with FT and OrgT overestimated the amount of time with 
tremor in the ‘whole day period’ estimations, I analysed the agreement between 
diary and actigraphy measures in more detail by assessing each of the ‘intra-day 
interval’ estimations as recorded in diaries and actigraphy over the five days (Figure 
7.2). Bland-Altman analysis showed a significantly better agreement between 
methods in the OrgT group compared to the FT group (OrgT: mean bias = +27.6%, 
95% CI –26.0 to 81.2; FT: mean bias = +64.7%, 95% CI 1.2 to 128.1). According to 
this analysis, intra-day interval estimations of patients with OrgT showed 
approximately 28% more tremor duration in diaries than by actigraphy. In contrast, 
patients with FT showed 65% more tremor duration in diaries than by actigraphy. 
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The fairly random spread of data points in Figure 7.2 with regard to the x axis 
indicates that bias was not proportional to the mean of tremor duration estimates 
and actigraphy, but rather subjects had an absolute systematic bias towards 
overestimation of tremor. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 7.1. Tremor duration as percentage of the waking day (mean ±standard 
deviation), as recorded in self-report diaries and by actigraphy, in patients with 
“organic” tremor (OrgT) and Functional tremor (FT). 
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Figure 7.2. Bland-Altman plots for tremor duration as percentage of the intra-day 
intervals, recorded in self-report diaries and by actigraphy, in patients with “organic” 
tremor (OrgT) (A) and functional tremor (FT) (B). All values from each participant are 
represented by the same symbol. Bias is expressed by the mean of the differences 
between methods and 95% confidence intervals (±1.96 SD). A difference of 0 (dotted 
grey line) represents the perfect agreement between both methods. Differences with 
positive values indicate an overestimation of tremor duration in diaries compared with 
actigraphy. Differences with negative values indicate an underestimation of tremor 
duration in diaries. 
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I additionally assessed intensity and duration of tremor at the time when patients 
were supposed to be filling in the diaries. Although I gave them instructions to fill in 
the diary at particular times of the day, I cannot be completely sure that they 
strictly followed the instructions. The most reliable moment that we believe we can 
be certain that the patients were filling the questionnaire was at bedtime. I 
therefore analysed the intensity and duration of tremor during the 30 minutes 
before going to bed. I did not find any increase in the intensity of tremor during this 
period in either group. However, for tremor duration, when I calculated the ratio 
between the percentage time with tremor over the 30 minutes before going to bed 
compared with the percentage time with tremor over the whole third interval (from 
7:00pm to bedtime), I observed significant differences between groups (p=0.01). 
The FT group had a ratio of 1.7 (indicating an increase of tremor during the 30 
minutes before going to bed with respect to the rest of the interval) whereas the 
OrgT group had a ratio of 0.7 (indicating a decrease of tremor in the 30 minutes 
before going to bed).  
In the post-study questionnaire, all patients answered that they believed that the 
purpose of the study was to monitor tremor, and that the watch was recording 
tremor 24 hours a day. 
7.4 Discussion 
In this study I have assessed duration and intensity of tremor in patients with FT 
and OrgT by using a validated long-term actigraph during five days and 
simultaneous self-rated measurements. I have demonstrated a remarkable absence 
of tremor during most of the waking day in patients with FT. Despite this, patients 
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with FT reported tremor to be present the majority of the time. In comparison with 
OrgT patients, they reported tremor to be present a significantly higher proportion 
of the waking day, and compared with the results of actigraphy showed a 
significantly greater bias towards over-estimation of tremor. 
Patient groups were well matched in terms of objective clinical assessment of 
tremor severity at baseline. In line with their estimates of tremor duration, but not 
with the actigraphy data, patients with FT rated themselves as significantly more 
disabled by tremor (Sub-scale C of the FTM scale), and as having a significantly 
poorer quality of life as rated by the EQ-5D (Brooks R, 2003). 
7.4.1 Implications for understanding the pathophysiology of 
functional tremor 
I suggest that these data provide supportive evidence that the majority of patients 
with FT (and perhaps by inference other functional disorders) are not malingering. I 
was explicit in my explanation of the study to the patients, specifically explaining 
that we were using a “tremor watch” to record the actual duration of their tremor 
and were comparing this with patients’ own estimates of tremor duration. I gave 
patients the opportunity to abort the study at any point. Two of the patients with 
FT we approached for the study initially accepted our invitation to take part, but 
then returned the actigraph to us without wearing it or completing diaries. The 
reasons given for this (arm pain, allergic reaction) may be genuine, but could also 
be hypothesised to be excuses to avoid revealing that tremor was not present when 
unobserved, compatible with the diagnosis of factitious disorder/malingering. 
However, in the rest of the FT group patients completed the study in a similar 
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fashion to “organic” patients. This behaviour, given the explicit study design, seems 
incompatible with malingering or factitious disorder, and instead suggests a 
genuine perception that tremor was present to the extent reported in the diaries. 
If malingering/factitious disorders are not explanations for the tremor in this group 
of functional patients, how might these data inform our understanding of the 
mechanism of symptom production? I believe that these data reflect the interaction 
between perception (diary assessments) and real sensory data (actigraph 
measurements). In an ideal neural model these would be identical (i.e. all sensory 
data is correctly translated into perceived tremor), but it is clear from personal 
experience and numerous experimental studies that perception of sensory data is 
dramatically altered by expectation (Koyama et al., 2005, Colloca et al., 2008, 
Bulsing et al., 2010). For example, perception of pain can be radically altered by 
expectation of the intensity of the pain stimulus (Koyama et al., 2005, Colloca et al., 
2008).  
Similarly, I suggest that my data reflect prior expectations about tremor in both 
functional and “organic” patients and how this can influence the way they 
estimated their tremor. Both patient groups overestimated their time with tremor, 
and this could be conceptualised as an over-weighting of prior expectancy about 
having tremor over actual sensory data. Such overvaluing of prior expectancy is 
indeed the norm in most studies of perception in healthy populations, and may 
reflect an evolutionarily beneficial tendency to value past experience over new 
sensory information (Elze et al., 2011).  
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However, my data with regard to the significantly greater estimation/actigraph 
mismatch in patients with FT fits with an abnormal weighting of prior expectancy in 
this patient group such that it overwhelms sensory data that should inform the 
patient that they do not have tremor. I hypothesise that whenever patients’ 
attention is turned towards the symptom (for example during clinical examination 
or as demonstrated in the present study, around the time they had to fill in the 
diaries) the expectation of the sensory consequences of the symptom is of 
sufficient strength to drive the abnormal motor behaviour. On the contrary, when 
attention is diverted away from the symptom (for example during most day-to-day 
behaviour away from the clinic) tremor stops. However the patient’s perception, 
which is moulded by the dominance of the abnormally strong prior expectation 
over sensory data, remains that tremor is present most of the time.  
7.4.2 Implications for clinical trials in functional tremor 
This is the first study to assess FT objectively in a “real-life” ambulatory fashion. To 
date, information regarding severity of symptoms in FT has been provided by 
objective face-to-face clinical observation using standardised rating scales such as 
the FTM or from patient self-report (Jankovic et al., 2006, McKeon et al., 2009). My 
data demonstrate that although intensity and severity of FT, when present, is 
similar to OrgT measured by actigraphy and rated using standardised scales, 
patients’ self-reports do not capture the reality of tremor duration in day-to-day 
life. This finding has implications for design of future clinical trials. In essence, my 
data suggest that the disability reported by patients with FT is not due to the 
tremor itself, but more to their abnormal perception that the tremor is continually 
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present. This would argue for the use of global disability and quality of life 
measures along with specific tremor assessments, as outcomes in clinical trials in 
this condition. 
7.4.3 Limitations 
I acknowledge some limitations to this study. Firstly, I have studied a small cohort 
of functional and “organic” tremor patients, and I cannot exclude that in a larger 
cohort data may be different. However, I chose patients with clinically typical 
(albeit longstanding) functional and “organic” tremor diagnosed using standardised 
criteria and feel that they do accurately represent patients with these diagnoses. 
Secondly, I cannot rule out that the actigraph was underestimating tremor in both 
groups as in a previous study 71% of 10 minutes of tremor observation were 
classified as tremor by the actigraph (Van Someren et al., 2006). However, studies 
using EMG, which is more sensitive to tremor than actigraphy (Spieker et al., 1997), 
have found patients with PD to have tremor 28.9% of a 24 hour period and patients 
with Essential Tremor to have 15.8%. These results are similar to my data in the 
OrgT group. Thirdly, I cannot completely exclude the possibility that tremor was not 
accurately recorded by actigraphy in patients with FT because of the known 
variability in FT frequency. However, this seems to be unlikely since the filters for 
tremor were set over a wide range (3 to 11Hz). Fourth, even though participants 
were clearly instructed, we cannot exclude that they overestimated tremor 
duration because tremor involving other body parts was also reported. 
Nevertheless, the majority of patients with FT had tremor only in the arm wearing 
the actigraph, and consequently, this explanation is unlikely to account for the 
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excessive overestimation of tremor in the FT group. Fifth, I set up arbitrarily only 
three intra-day interval estimations. It is possible that with shorter intervals, results 
would have been different as participants would have thought about the tremor 
more often. However, I wanted to assure the correct completion of the study and I 
felt three times a day was an achievable number for most of the participants. Six, I 
studied patients with FT and no other FMD and one can argue that these results do 
not apply for other FMD. Indeed, it seems less likely that patients with functional 
fixed dystonia display their symptoms for short periods of time due to the presence 
of muscle contractures and shortening of tendons commonly seen in some of these 
patients (which would reflect somehow that the abnormal movement is present 
most of the time). Seven, although on average patients with FT had 31 minutes of 
tremor a day, there may well be patients with FT who have more tremor, if their 
attention is turned towards it more often. Finally, I acknowledge that assessment of 
the presence or absence of malingering is very difficult and my data cannot fully 
exclude this possibility and therefore that there was some purposeful 
embellishment in the way functional patients completed the diaries. However, a 
post-study questionnaire indicated their understanding of the nature of the study 
and I feel malingering is an unlikely explanation of my results. 
7.5 Conclusions 
In this study, I have demonstrated a dramatic overestimation of duration of tremor 
in patients with FT compared with estimates of patients with OrgT and ambulatory 
actigraphy. Our data do not support the hypothesis that these patients are 
malingering. Instead, these data may reflect an abnormal perception of tremor in 
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patients with FT who might overweight their expectancies regarding tremor 
duration. 
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Chapter 8: A study assessing the lack of sense of agency 
for movement in functional movement disorders. 
 
This is a pre-copyedited, author-produced PDF of an article accepted for publication in Brain 
following peer review. The version of record [Pareés I, Brown H, Nuruki A, Adams RA, 
Davare M, Bhatia KP, Friston K, Edwards MJ. Loss of sensory attenuation in patients with 
functional (psychogenic) movement disorders. Brain. 2014 Nov;137(Pt 11):2916-21] is 
available online at: http://brain.oxfordjournals.org/content/137/11/2916.long. 
8.1 Introduction 
So far, I have provided evidence for an abnormal attentional focus towards 
movement in patients with FMD. However, this requirement of attending to the 
movement for the dysfunction to manifest might be expected to be associated with 
a strong sense of “voluntariness” or agency for the movement, which is in marked 
contrast to what patients with FMD report: they experience the abnormal 
movement as involuntary. This issue is at the heart of a centuries old debate on the 
level conscious fabrication/manufacturing of functional symptoms. If feigning is not 
an explanation for the vast majority of patients with FMD, then the logical 
conclusion must be that these patients have an impairment of the mechanisms 
implicated in the ability to recognize that one is initiating and controlling one's own 
actions, i.e. the sense of agency for movement.  
After reviewing the literature, I decided to assess the phenomenon of sensory 
attenuation (SA), which is considered to be an implicit measure of the sense of 
agency (Blakemore et al., 2002).  
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In brief, SA is the phenomenon whereby the intensity of sensation generated by 
self-generated movement is reduced (Blakemore et al., 1998, Blakemore et al., 
2000, Shergill et al., 2003). A common example of this is the observation that while 
one cannot tickle oneself, one can be tickled by others. The experience of SA is 
important in labelling movements as self-generated and a loss of SA has been 
proposed to lead to a loss of agency for movement (Blakemore et al., 2002). In the 
experimental setting, SA has been most commonly assessed with a force matching 
paradigm (Shergill et al., 2003, Shergill et al., 2005, Voss et al., 2007, Teufel et al., 
2010).  Here, subjects are asked to match a force delivered to their finger, either by 
pressing directly on their own finger with the other hand, or by operating a joystick 
that, via a non-linear transform, causes a robot arm to press down on their finger. 
Healthy subjects consistently generate more force than required when directly 
pressing on their finger compared with using the joystick, where they are much 
more accurate. It has been proposed that the excess force exerted in the first 
condition reflects SA of the sensory consequences of self-generated movements, 
something not present in the second condition, where the highly nonlinear 
transform between movement and sensation disrupts the sense of agency.  
I felt that exploring SA in patients with FMD would provide an opportunity to assess 
a key psychophysical property of movement that is experienced as self-generated 
or voluntary in this group of patients. I predicted that if patients with FMD had 
impairment in the sensory attenuation mechanism, they would be more accurate 
than controls matching forces when directly pressing on their finger. 
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8.2 Methods 
8.2.1 Participants 
Fourteen patients with FMD were selected from the General Movement Disorder 
clinic of Dr Mark Edwards or Professor Kailash Bhatia as well as from the specialised 
Functional Movement Disorder run by Dr Edwards, at the NHNN Queen Square, 
London, UK. The specific study was personally explained in detail and if the patient 
expressed interest in participating, a formal letter with a full description of the 
study and stating the date and location of the experiment was sent. 
Inclusion criteria were: 
1. Age over 18 years.  
2. Diagnosis of clinically established or documented FMD according to Fahn 
and Williams criteria (Fahn and Williams, 1988).  
3. The FMD was not affecting the upper limbs to ensure the correct 
accomplishment of the motor task. 
I used as exclusion criteria: 
1. Age less than 18 years. 
2. Unable to communicate with researcher (e.g. does not speak English).  
3. Presence of sensory symptoms or sensory abnormalities (detected on 
physical examination).  
The control group consisted of 14 healthy participants who were recruited from a 
Departmental pool of volunteers and from patients’ relatives who wished to 
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collaborate with the research. They were matched with respect to gender, age, and 
handedness. 
8.2.2 Questionnaires 
8.2.2.1 Handedness 
Hand dominance was assessed by the Edinburgh Handedness Inventory (Oldfield, 
1971), which has been previously described in this thesis. 
8.2.2.2 Mood 
We administered the HADs to all participants to assess their mood the week prior 
to testing, which has been also previously described in this thesis (Zigmond and 
Snaith, 1983).  
8.2.2.3 Intelligence level 
To estimate the non-verbal intelligence level (IQ) of participants, the 12 items short 
form of Raven's Progressive Matrices test was used, previously described in this 
thesis (Raven JC, 1977).   
8.2.2.4 Delusional ideation 
Delusional ideation was assessed using the PDI-21, as previously described (Peters 
et al., 2004).  I decided to match both groups by delusional ideation because 
healthy individuals with higher scores in delusional questionnaires have been 
previously found to have a less amount of SA (Teufel et al., 2010).  
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8.2.3 Materials 
A small, desk-mounted force-feedback robot arm (PHANTOM® Desktop™ Haptic 
Device, Sensible Technologies, Cambridge, MA, USA) was programmed to apply 
different forces over a custom-made force transducer, which was placed on the top 
of the subject’s left index finger. The force output was recorded by a programmable 
output system (Spike 2, version 6, Cambridge Electronic Design (CED), UK). 
8.2.4 Experimental Design 
I tested each participant in a single experimental session consisting of two main 
conditions: matching a target force, either by 1) pressing on themselves with the 
right index finger on the left index finger (self-condition) or 2) by manipulating a 
robot which pressed down on the left index finger (external-condition). Five 
different target forces (16 trials of each), increasing in increments of 0.5 Newton (N) 
from 1N to 3N, were randomly presented in both conditions. All subjects completed 
a total of four blocks of 20 trials each (80 trials in total) for each condition. The 
order of conditions was counterbalanced across participants. 
8.2.5 Procedure 
Participants sat in front of a table and placed the tip of their left index finger under 
the force transducer. The finger was taped to the table to avoid any movement. In 
the self-condition, the robot exerted one of the five constant target forces in each 
trial for 3s. After 2s of rest, an auditory “go” signal told the participants when to 
start matching the target force – by directly pressing with their right index finger for 
3s onto the force transducer resting on the left index finger (Figure 8.1). A “stop” 
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auditory signal marked the end of the trial. In the external-condition the robot 
exerted one of the five constant target forces in each trial for 3s. After 2s, an 
auditory “go” signal warned the participant to start matching the target force by 
moving the arm of a second robot horizontally, which controlled the output of the 
other robot that applied a force vertically to the left index finger (Figure 8.1). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.1. Experiment set-up. A) Self-condition. A constant force is delivered by one 
of the robots on the participant’s left index finger. Immediately afterwards, 
participants had to match the force by pressing with their contralateral index finger. B) 
External-condition. A constant force is delivered by one of the robots on the 
participant’s left index finger. Immediately afterwards, participants had to match the 
force by moving the arm of the second robot horizontally – to control the first robot’s 
output. 
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The force level generated by the subject was calculated for each trial by taking the 
mean force recorded by the force sensor between 2000 and 2500ms after the go-
signal. We calculated the ratio between the matched force and the target force for 
both conditions (ratio > 1 indicating generation of excessive force) and this was our 
measure of SA. This measure was averaged across trials to give the mean 
attenuation for each force level and condition. 
8.2.6 Statistical analysis 
SPSS Statistics software (version 21.0.0) was used for the statistical analysis. 
Normality of errors was assessed by using the Kolmogorov-Smirnoff test. When not 
normally distributed, the data were subjected to a Log10 transformation. P-values 
for categorical variables were calculated with the use of Fisher’s exact test. U-
Mann-Whitney test was used to compare differences in means for numerical data 
in baseline characteristics.  
A repeated-measures ANOVA was used to compare the results of the main 
experiment with CONDITION (Self vs. External) and FORCE (1N, 1.5N, 2N, 2.5N, 3N) 
as main factors and GROUP (patients vs. healthy participants) as a between-
subjects factor. Post-hoc tests were conducted with Bonferroni corrections for 
multiple comparisons. We calculated potential associations between IQ, PDI-21 and 
HADs and the amount of SA (calculated as the mean of the ratios for each force 
level in the self-condition) by using Pearson’s correlation. Statistical significance of 
p<0.05 was assumed. 
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8.3 Results 
Baseline characteristics of the participants are shown in Table 8.1. Patients and 
healthy participants were matched for age, gender, handedness, Raven’s and PDI 
scores. Most patients had fixed dystonia of the lower limbs as FMD. Clinical 
features included an acute onset and rapid escalation of the symptoms. Most 
presented dramatic response to placebo or following examination under 
anaesthesia and dystonic symptoms often disappeared for a period of time to recur 
later on. Most patients were females which is consistent with the majority of them 
having fixed dystonia, as there is female predominance in this group of patients. 
None of the patients was treated with antipsychotic medication.  
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Table 8.1. Demographic and clinical characteristics of the participants in the 
sensory attenuation study 
 FMD Healthy control P value 
Age (years)      
     Median (range) 
 
38.1 (30 - 67) 
 
34.5 (29-58) 
 
0.12 
Sex, n (%) 
     Male 
     Female 
 
1 
13 
 
4 
10 
0.32 
Handedness 
     Right 
     Left 
 
12 
2 
 
14 
0 
0.48 
Type of FMD, n (%) 
     Fixed dystonia 
     Functional tics 
     Functional palatal tremor 
     Functional hemifacial spasm 
     Paroxysmal movement disorder 
 
10 
1 
1 
1 
1 
 
NA 
NA 
NA 
NA 
NA 
 
HADS total score 
     Median (range) 
 
13 (0-28) 
 
4 (0-28) 
 
0.002 
Raven’s score 
     Median (range) 
 
10 (6-12) 
 
11 (9-12) 
 
0.94 
PDI-21 score 
     Median (range)  
 
12.5 (0-63) 
 
12.5 (0-30) 
 
0.98 
FMD = Functional movement disorder    
 
A repeated-measures ANOVA showed a significant CONDITION x GROUP interaction 
(F=6.54, df=1, 26, p=0.017). Post-hoc explorations of this interaction revealed that 
this was due to the patients having significantly less attenuation than healthy 
controls in the self-condition (F=8.47, df=1, p=0.007) but no significant difference 
from healthy controls in the external condition (F=0.145, df=1, p=0.706). 
When I analysed patients alone, I found no significant differences in their 
performance when self and external-conditions were compared (F=2.62, df=1, 13, 
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p=0.129). In contrast, healthy controls significantly overestimated the force 
required in the self- condition compared to the external-condition (F=26.64, df=1, 
13, p<0.001). 
I present the raw data in Figure 8.2.  
 
 
 
 
 
 
 
 
 
 
 
Figure 8.2. Results of the force matching paradigm. Healthy controls (dashed blue line) 
significantly overestimated target forces in the self-condition compared with patients 
with functional motor symptoms (dashed red line). There were no differences in the 
external-condition between healthy controls (solid blue line) and patients (solid red 
line). Colour shadows represent the standard error of the mean for each condition. 
 
I found no significant correlation between duration of symptoms and SA (r=0.007, 
p=0.98). There were no correlations between HADs or Raven’s scores and SA 
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(r=0.29, p=0.91; r=0.147, p=0.62 respectively). PDI-21 total score did not correlate 
with the amount of SA (r=-0.67, p=0.82). We calculated a new score as the sum of 
the score of just those items in the PDI-21 that imply somehow passivity experience 
(i.e. questions 10, 18, 19, 20 and 21). No significant correlation was found between 
this score and the amount of SA. 
8.4 Discussion 
In this study, I have assessed the phenomenon of SA as a measure of self-agency, in 
patients with FMD. I have demonstrated that patients with FMD have a loss of SA in 
a force-matching task compared with healthy control subjects. As expected, healthy 
controls consistently overestimated the force required in the self-condition, 
whereas patients did not, and were actually extremely accurate in their force 
estimation performance when using their own contralateral index finger. In 
contrast, both patients and control behaved exactly the same in the external or 
control condition, when they manipulated a second robot to match the different 
forces.  
SA has been observed in auditory, visual and tactile domains (Martikainen et al., 
2005, Cardoso-Leite et al., 2010, Hughes and Waszak, 2011, Desantis et al., 2012) 
and attenuation of Blood Oxygen Level-Dependent (BOLD) responses and 
Somatosensor Evoked Potentials (SEP) related to self-generated sensations has also 
been demonstrated (Cohen and Starr, 1987, Blakemore et al., 2000). Over the past 
decade, the most prominent theoretical account of the phenomenon has been 
based on motor control theory, where an efference copy of a motor command is 
used to generate a “corollary discharge” – a prediction of the likely sensory 
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consequences of that movement (Blakemore et al., 1999). When movement occurs, 
sensory feedback is compared with the sensory prediction and – after a 
“subtraction” process – any mismatch can be used to update future commands. It is 
proposed that in voluntary movements, predictions of sensory consequences are 
very accurate and therefore there is little or no mismatch between predicted and 
actual sensation. This lack of mismatch is assumed to attenuate the perceptual 
consequences of self-produced movements and may be the cause of force 
overestimation in the force matching task. Temporal and spatial offsetting between 
the movement and its sensory consequences causes a gradual decline in SA 
(Blakemore et al., 1999) Thus the degree of SA is proposed to index in some 
manner the “voluntariness” of movement. Conversely, lack of SA has been 
proposed to reflect a lack of agency for self-generated movement (Shergill et al., 
2005). 
However, some difficulties with the classical model of SA have recently been 
highlighted (Brown et al., 2013). For instance, different experiments have 
demonstrated that attenuation of externally generated sensations is possible, 
which, by definition, cannot be predicted by the forward model of the sensory 
consequences of movement. Also, SA commences before the onset of a movement 
(Bays et al., 2006), and is not related to the predictability of the stimulus (Bass et 
al., 2008). A different approach based on a Bayesian model of the brain has been 
recently developed to explain SA (Brown et al., 2013). Under this framework, 
attention plays an important role modulating the suppression of the sensory 
consequences of voluntary movement and inferring about internally and externally 
generated sensations. This will be discussed in more detail in the next chapter.  
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Patients with schizophrenia and healthy individuals with high scores delusional on 
questionnaires probing delusional beliefs have been also found to have reduced SA 
using a similar paradigm (Shergill et al., 2005, Teufel et al., 2010). These results 
have been explained on the basis of a dysfunction in generation of accurate internal 
predictive models related to movement, which might be responsible for delusions 
of control (or the abnormal belief that one’s own actions are controlled by an 
external force).  Despite this, psychotic symptoms are not a feature of patients with 
FMD, and I did not find differences between delusional ideation measured by PDI-
21 between my patients and healthy controls. It is therefore likely that although 
patients with schizophrenia and FMD share the same abnormalities in the SA, they 
have different primary causes.  
It is important to note that other studies have aimed to explore agency for 
movement in patients with functional motor symptoms. However, the employed 
methodology makes interpretation difficult. For instance, in a study using fMRI, a 
relative reduction in activation of the right inferior parietal lobule was found in 
patients with functional tremor comparing activation patterns while they were 
tremoring and when they were voluntarily producing tremor (Voon et al., 2010). 
Although right inferior parietal lobule is considered to be important in sense of 
agency, these data only indirectly address the question of reduced sense of agency 
in patients with functional motor symptoms. Two other studies have shown that 
patients with FMD judged the feeling of intention to move significantly closer to the 
action of moving compared to control participants and had a decreased action-
effect binding when making voluntary movements compared with healthy 
volunteers (Edwards et al., 2011, Kranick et al., 2013). However, both studies rely 
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on subjective self-report and are clearly susceptible to important biases. Finally, a 
recent study has shown that patients with functional paresis display distinct 
electroencephalographic markers compared to feigners (Blakemore et al., 2013). 
Among other results, they found that P3 event-related EEG potentials component 
was enhanced when the symptomatic hand was moving in contrast to feigners, and 
they suggested that this might be related to the lack of awareness that patients 
have about the origin of their symptoms.  Unlike the previous studies, I believe that 
the paradigm employed in my study provides a more direct demonstration that a 
key component of normal movement related to sense of agency, and which is 
immune to feigned poor performance, differs from healthy controls. Patients fail to 
attenuate the sensory consequences of self-produced movement and therefore 
they were extremely accurate matching forces as compared to healthy controls. 
Data such as these support that feigning is not a satisfactory explanation for the 
majority of patients with functional symptoms and support that abnormalities in 
the sense of agency for movement underlie this disorder.  
I acknowledge a number of limitations of this study. First, the sample size is small 
and I cannot exclude that in a larger cohort data may have greater statistical 
efficiency. However, we chose patients with clinically typical FMD using 
standardized criteria and feel that they do accurately represent patients with this 
diagnosis. Furthermore, the fact that I was able to show a significant group by 
condition interaction with a relatively small sample size suggests the effect sizes in 
question are relatively large. Secondly, it is important to note that functional 
tremor is considered the most common FMD and that in our sample, most patients 
suffered from functional fixed dystonia, which is considered to be the second 
153 
 
commonest diagnosis. This is likely to be due to the exclusion criteria used in this 
study. Patients with FMD involving upper limbs were not included and this is the 
body part usually affected by functional tremor. Thirdly, while the self and external-
conditions were significantly different in controls we did not find the same amount 
of SA in healthy controls compared with previous studies (Shergill et al., 2003, 
Shergill et al., 2005). One possible explanation is that the experimental set-up 
differed from that used in previous literature. Fourthly, this study does not resolve 
the important question of why patients with FMD showed impaired SA in the force-
matching task using non-affected body parts. I believe that one possible 
explanation is that lack of SA is a trait (perhaps related to the self-focussed 
attention that these patients display), which predisposes them to develop 
functional symptoms. It is of note that a proportion of patients with functional 
symptoms develop progression and spread of symptoms over time, and while the 
initial onset of symptoms is quite commonly associated with a physical or 
psychological trigger, spread of symptoms is often apparently spontaneous. Further 
studies in asymptomatic patients with a previous history of FMD would clarify this 
important question.  
In conclusion, patients with FMD display impairment in SA mechanism measured by 
a force matching task. This might contribute to explaining the paradox of why 
movements that superficially resemble voluntary movements are experienced as 
involuntary in this group of patients.  
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Chapter 9: General discussion and conclusions 
Part of the discussion described in this chapter has been also written as a review article: 
Edwards MJ, Fotopoulou A, Pareés I. Neurobiology of functional (psychogenic) movement 
disorders. Current Opinion in Neurology 2013; 26: 442-7. 
In this thesis I have explored different aspects of the pathophysiology of FMD. As I 
mentioned in the introduction, I took as my starting point the manner in which the 
diagnosis of FMD is made in neurological practice and I focused on a mechanistic 
rather than on an etiological level.  
The findings of the different studies described here suggest that physical illnesses 
preceding the onset of FMD, abnormal focus of attention to movement, abnormal 
beliefs about the symptoms as well as an impairment in the sense of agency for 
movement are elements that play an important role in the mechanism underlying 
FMD and that it would be important to incorporate these concepts in any model 
seeking to explain this perplexing condition.  
In this final chapter I will discuss my results in the light of previous theories, I will 
discuss in more detail the methodological limitations of each of my studies and 
make suggestions for improvements. Finally, I will suggest directions for future 
research.  
I started saying that one of the main aims of this work was to try to better 
understand the circumstances surrounding the onset of FMD. I have mentioned 
how functional symptoms have been typically interpreted as a result of previous 
psychological stressors, even if they preceded the onset of symptoms by decades. 
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This was the main argument of most of 19th/early 20th century theories, especially 
the Freudian one and is still ingrained within much of modern medical practice. 
Likewise, I have highlighted how physical events closely preceding the onset of 
functional symptoms have been previously described in the literature although 
their role in symptom generation has remained less defined. For instance, Janet 
proposed in his dissociation theory that the restriction of the field of consciousness 
usually affects a function that has previously become weak. He proposed that 
previous physical illness involving the same body part affected by the functional 
symptom was a potential causes for this weakening. In the case of Freud, he 
proposed that it is actually the psychological stress that accompanies the physical 
trauma that is the cause of the functional symptoms rather than the physical injury 
itself. As part of the analogy with an electrical system that Freud used to explain 
brain function, he considered that any physical illness affecting the body part 
concerned could work as by potentially weakening the resistances that prevent the 
distribution of the abnormally increased brain excitation in patients with function 
al symptoms to other organs. 
Based on these observations, in the first study of this thesis I aimed to investigate 
how often patients with FMD report a physical event close to the onset of 
functional symptoms in a systematic way. I recruited 50 consecutive patients and 
studied them with a semi-structured interview. I found that most patients that 
attended our clinic described a clear physical problem closely preceding the FMD 
and that often, these were phenomenologically related to the functional symptom. 
Rather than weakening factors, as proposed by 19th century’s theories, I speculated 
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on the potential role of physical events in generation of functional symptoms. I 
suggested that they may provide initial sensory information that, along with other 
cognitive and psychological factors, form the substrate for the development of a 
specific FMD in vulnerable subjects.  
However, it is important to acknowledge that although the causality between the 
physical illness and the subsequent FMD sounds plausible, it cannot be established 
with the results of a retrospective study and therefore my results should be 
interpreted with caution. Important methodological limitations that need to be 
underlined are: first, that I relied on the information obtained during a semi-
structured interview and I did not verify the biopsychosocial background of the 
patients as well as their previous history including medical details of the physical 
event and the onset of the functional symptoms by accessing patients’ medical 
records from the two medical contact points initially used by most patients (GP 
surgeries and A&E Services). Second, although it was not the main scope of my 
study, I assessed life events occurring within the same time window used to assess 
the presence of physical event by using a standard questionnaire. I have already 
acknowledged how difficult the assessment of life events is, especially with regard 
to recall bias. One way to decrease the recall bias would have been the use of a 
more reliable method, for instance the Life Events and Difficulties Schedule (Brown 
GW, Harris TO, 1979). Here, information about specific life events, timing and 
relevant contextual information is collected by a panel of raters but the 
participant’s report of his or her reaction to the event at that time is ignored. Based 
on the contextual information, the threat for each event is rated.  
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However, the ultimate approach to avoid any recall bias and clarify the potential 
causality between physical events and the generation of FMD would have been to 
design a prospective multicentre study. Further studies could, for instance, recruit 
patients presenting in different GP surgeries or A&E Services with some of the most 
commonly physical events found in my study. Regular follow ups during the next 
month and examination of suspected cases of FMD within that period by trained 
neurologists would permit the identification of the cases and draw conclusions 
about causality. However, the large cohort required in order to obtain a reasonable 
number of cases as well as the likely costs of such a study make this approach less 
feasible.   
 
The second study described in this thesis aimed to explore the role of attention in 
the generation of FMD. In one way, this was not a new area of study. We have seen 
how the role of attention in functional symptoms dates back to the dissociation 
theory of Janet. He proposed that in the case of patients with functional symptoms, 
the amount of sensations that can be perceived consciously is limited. He proposed 
that this is due to a spontaneous narrowing of their attention. The part of the mind 
that become “unattended” is then “dissociated” from consciousness, and the 
function of the resulting body part is impaired.  
Contradicting somehow this theory, we have seen that it is clinically obvious that in 
the case of FMD directing attention to the affected body part exacerbates 
functional symptoms and when attention is distracted away they often improve or 
disappear. In the study described in Chapter 6 I aimed to translate this clinical 
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observation to a more experimental setting. I used paradigms that had been 
previously used in motor physiology literature. For instance, I explored the 
capability of the brain to adapt to visuomotor distortions. Adaptation in this context 
is the reduction in systematic errors introduced by a 30 degree counterclockwise 
angle in the direction used to reach a target in order to return to the former level of 
performance. Adaptation to visuomotor rotation is widely considered a form of 
implicit motor learning. One reason is that subjects can adapt whilst being unaware 
that they are making systematic directional errors. Also, the adaptation occurs even 
when subjects are given explicit strategies to override it (Mazzoni P, Krakauer JW, 
2006). Adaptation to visuomotor rotation has been found to be normal in patients 
with other movement disorders such as patients with primary cervical dystonia 
(Katschnig-Winter P, et al, 2014)  and asymptomatic carriers with the genetic 
mutation for Huntington’s disease (Mazzoni P, Krakauer JW, 2009). In contrast, 
visuomotor adaptation has been found abnormal in patients with PD tested with 
similar paradigms (Venkatakrishnan A et al, 2011). I found that patients with FMD 
can adapt to visuomotor distortion to the same level than healthy subjects, 
suggesting that implicit motor control is intact.  
The paradigm used to explore explicit motor strategies in FMD was based in the n-
back task, previously used to assess working memory. Here, participants are fully 
conscious of the underlying task structure and therefore movement pre-planning is 
possible. This paradigm had been previously tested in healthy participants and 
patients with the genetic mutation for Huntington’s disease who performed with no 
difficulties (Mazzoni P, Krakauer JW, 2009). In contrast, I found that patients with 
FMD were impaired in this task, and had slower movement times than controls. 
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Interestingly, RT and accuracy to the trajectory did not differ from controls, 
suggesting that the execution of the movement was specifically affected.  
Finally, I used a cued choice reaction time task to assess how predictability about 
the movement may impact motor control en patients with FMD. I used a motor task 
that had been previously designed in the Sobell Department as an adaptation of the 
classical visual attention paradigm (Posner paradigm) for a motor setting. Briefly, in 
the classical Posner’s paradigm two levels of spatial attention are explored. In the 
first condition, voluntary/explicit orientating of attention to a visual target is 
assessed. Here, the target is preceded by an arrow located in the centre of the 
visual field (cue) which represents potential direction of the location where the 
subsequent target may appear. The interpretation of this cue requires a 
voluntary/explicit processing by the cognitive system. In the second condition, a 
more reflexively/automatic way to orientate attention to a visual target is assessed. 
The cue in this case is a peripheral cue displayed in the position where the target 
may appear. It automatically attracts attention in a more reflexive way without a 
clear voluntary/explicit processing by the cognitive system. In both conditions, cues 
can predict or not correctly the position of the target. Valid cues result in a 
decrease of the RT when participants respond about the position of the target 
compared with invalid cues.  In the paradigm used in my experiment, the subjects 
were asked to make a fast movement as soon as they detect a target in their visual 
field but instead of being presented with cues providing spatial information, the 
cues were arbitrarily mapped onto required finger movement responses. The 
advantage of this paradigm to study motor control was that attention is cued to the 
aspects of movement itself and not only to spatial attention. I hypothesised that 
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increasing predictability of a required movement would allow the opportunity for 
controlling the movement in a more explicit way. Therefore, I predicted that 
patients would exhibit a paradoxical motor impairment for the valid cues only in 
those conditions where the movement would be predictable. I found interesting 
results in this paradigm that deserve further comments. First, I found that the 
performance of patients with FMD was impaired only in the condition with higher 
predictability for the movement (95V). However, patients’ performance did not 
differ from healthy participants in the 75V condition, where the movement was also 
predictable although to a lesser extent. One can argue that this must be due to the 
fact that patients only employed explicit strategies when they were almost certain 
about the movement to perform. However, the possibility that these results are 
due to chance or other factors cannot be excluded. In this regard it would be 
interesting to test additional levels of predictability (i.e. 50V, 65V, 75V, 85V, 95V) to 
confirm these results. Also, it would be important to test other group of patients 
with other movement disorders to explore how having an abnormal movement 
itself may impact in this paradigm. Likewise, there is no data about how affective 
disorders may influence the results of this paradigm. The patients included in my 
study scored higher in HADs than healthy controls and it would be important for 
further studies to include a control group matched by affective symptoms.  
Taking into account all these limitations, the results suggest that movement 
impairment is restricted to tasks where conscious movement control in the setting 
of explicit movement production is possible, and not where movement occurs in a 
more automatic, implicit fashion. This is in agreement with the clinical observation 
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of these patients but it would argue against the classical “dissociation” theory that 
proposes that it is the inability to attend to the affected body part the likely cause 
of functional symptoms. Instead, I propose that it is an abnormal focusing of 
attention towards the movement (in case of FMD) which is essential for the 
generation of the symptoms.  
This view is in keeping with more recent theories about functional symptoms. 
Richard J Brown formulated in 2004 a novel theoretical framework for functional 
symptoms in which attention plays a central role (Brown, 2004). He suggested that 
in the normal physiological state, an attentional system controls the selection of the 
relevant sensory information from our body and the environment for further 
processing and control of actions. He proposed the primary attentional system as 
the one used to organize relevant sensory information into integrated multimodal 
perceptual units (primary representations) that provide a working account of the 
environment for the control of actions. When actions are well learned or become 
into routine behaviours, they are controlled by a hierarchical system of procedural 
representations (schemata) specifying the attentional, cognitive and motoric 
processes involved in executing well-learned actions.  This is a rapid system which 
consumes few processing resources. Behaviours controlled in this way are 
experienced as effortless. In situations where the system does not have the 
appropriate schemata such as in novel actions, these are controlled by a secondary 
attentional system (SAS) in a higher level of the system. Actions controlled by SAS 
are perceived as mentally demanding and associated with a sense of conscious 
volition and self-awareness (Brown, 2004). Brown explained the vulnerability of 
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some people to develop functional symptoms on the basis of self-focused 
attention. In the proposed model, the recurrent redirection of attention onto 
symptoms by the SAS is the primary pathogenic factor. Allocation of high level 
attention to symptoms serves to increase the activation of their brain 
representations and decrease the amount of activation required for it to be 
selected in the future. In this context, anything that increases self-focused attention 
can contribute to the development and maintenance of functional symptoms such 
as misattribution of symptoms to physical illness, negative affectivity such as 
anxiety and depression, illness worry and rumination, as well as previous traumatic 
experiences (Brown, 2004). 
My results are also in keeping with more recent studies. For instance, patients with 
FT have been shown to spend significantly more time directly looking at their 
affected limb during clinical examination compared to patients with “organic” 
tremor, suggesting a role for self-directed visual attention in generation of motor 
symptoms (van Poppelen et al., 2011). Also, a recent study that compared positron 
emission tomography of regional cerebral blood flow in a small cohort of patients 
with “fixed” functional dystonia and genetically-characterised primary dystonia as 
well as healthy controls showed that fixed dystonia patients had reduced blood 
flow in primary motor cortex and increased blood flow in basal ganglia and 
cerebellum, which was contrary to that seen in patients with genetic primary 
dystonia (Schrag et al., 2013). The authors suggested that the abnormal subcortical 
activations in functional patients could reflect problems with self-directed 
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attention/monitoring, perhaps related to fronto-subcortical circuits mediating 
motor attention. 
 
Along with attention, there is another element that emerges in this thesis and can 
play an important role in symptoms generation and have an important effect 
altering the sensory experience of them: the presence of symptom-related 
abnormal beliefs (understanding the concept of belief in this context as 
expectations about the symptoms).  
If we go back to the historical view about the pathophysiology of functional 
symptoms, we may remember that it was Janet himself who first acknowledged 
how expectations about symptoms may play a role in symptom generation. He 
described a patient who developed fixed dystonia in both legs because he thought a 
carriage had run over his legs although it was later demonstrated that no injury 
actually occurred.    
Interestingly, in this thesis I have found that patients with FMD required 
significantly less evidence than controls to make a judgement in the JTC paradigm, 
which could predispose them to appraise anomalous or ambiguous information 
rapidly and produce (abnormal) beliefs on the basis of limited evidence, without a 
thorough consideration of alternatives or a review of the evidence. One could 
suggest that such a reasoning style, along with other factors, may predispose 
patients with FMD to abnormally process sensory data arising from a triggering 
event (which we have seen can be often a physical illness) and easily form the 
abnormal belief that the sensation represents a symptom of a neurological disease.  
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One important limitation of this study is that patients with FMD scored higher than 
healthy controls in the HADS. I acknowledged in chapter 5 that affective 
disturbances were not a predictor of the results obtained in my sample (as assessed 
by a regression analysis) and this would fit with other studies that also failed to find 
a relationship between affective disturbances and the JTC bias. However, the 
specific impact of affective symptoms in probabilistic reasoning bias is still to be 
elucidated and I cannot exclude that they partially explain my results. Further 
studies will therefor need to clarify whether the JTC bias is specific to the functional 
condition itself or instead relates to the affective symptoms that commonly 
accompany FMD. Either comparing patients with FMD with and without 
depression/anxiety symptoms and a healthy control group or matching by affective 
symptoms a group of patients with FMD and a group of depression/anxiety patients 
with no FMD would help to answer this question.  Also, I used only one 
combination of beads in my study and it has been shown that task difficulty may 
influence the results of in the probabilistic reasoning task (Young HF, Bentall RP, 
1997). Participants are more certain in easier (85:15 ratio) than in difficult versions 
of the bead task (60:40 ratio). Therefore, I cannot exclude that manipulating the 
ratios of the beads in the containers the results in patients with FMD might be 
different. Further studies could then assess the performance of these patients with 
different ratios. One could argue that if these patients display a JTC bias because 
they weight the initial information differently from normal subjects (as I have 
proposed), they would express greater certainty in easier conditions (85:15) 
compared with the most difficult one (60:40).  
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A reflection that abnormal beliefs about symptoms may be implicated in symptom 
generation also comes from the study described in Chapter 7 assessing FT in real 
life conditions. Here, I demonstrated that when patients with functional and 
“organic” tremor were asked to wear an accelerometer in their most affected hand 
in term of tremor, which constantly recorded and stored data over 5 days, both 
patient groups subjectively overestimated the amount of time they had tremor, but 
functional tremor patients did this to a much greater extent. I suggested that this 
significant exaggeration of a natural bias in tremor patients to overestimate tremor 
duration could reflect abnormal high level beliefs about there being constant 
tremor present. An abnormally strong prediction or expectation about the 
symptom may override the real sensory data from the affected limb tremor that 
should alert the patient that tremor is not there most of the time. Therefore, 
periods without tremor are simply not perceived. I have already acknowledged 
limitations in to this study but I think it is important to consider two additional 
aspects when interpreting my results. First, most patients with “organic” tremor 
had idiopathic PD. Although I matched both group by tremor characteristics and 
severity by using the FTM scale, it is likely that PD patients had predominantly rest 
tremor. One could argue that because rest tremor causes almost no functional 
disability it can be unnoticed and not reported in the diary. This could explain 
partially why the “organic” group did not overestimate tremor duration at the same 
level than functional patients. Second, there was a statistical trend for patients with 
“organic” tremor to be older than patients with FT. Although our patients did not 
have significant cognitive impairment, I cannot rule out that this factor was also 
influencing the way patients were reporting subjectively their tremors. Therefore, if 
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similar studies are designed in the future to replicate my results, it would be 
important, apart from increasing the sample size, to match groups by age and select 
a more homogenised control group with predominately postural tremor, which is 
clearly functionally disabling and are less likely to be unnoticed (i.e. patients with 
essential or dystonic tremor).  
 
The last element emerging from this thesis is the sense of agency relating to 
movement (in other words that one is or is not the cause of the movement of one’s 
body). This is perhaps the most intriguing aspect of patients with FMD, and the one 
which perhaps has caused most difficulty in their interaction with healthcare. Their 
movement abnormalities have features typical of voluntary movement and yet they 
report them to be involuntary. The question of whether they are in fact malingering 
symptoms is impossible to resolve in most ordinary clinical situations.  Indeed, it 
has been always the centre of debate. We have seen how Charcot and Janet 
advised about the difficulties of differentiating patients with functional symptoms 
from feigners. We have also seen how some of them, as in the case of Charcot, 
argued that most patients with functional symptoms were actually not feigning and 
aimed to prove it experimentally by designing specific devices (a plethysmograph-
like machine to assess breathing regularity and fatigue in patients with fixed 
dystonia and healthy subjects maintaining voluntarily the same abnormal posture 
against a continuous traction).  
In this thesis, I have shown that the SA phenomenon (proposed to be a measure of 
the sense of agency for movement) is impaired in patients with FMD. I used the 
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force matching paradigm which has been largely assessed in healthy volunteers and 
has been demonstrated to be abnormal in patients with delusions or at high risk of 
delusional state. I have shown that patients with FMD, similar to those with 
delusions and in contrast with healthy controls, did not overestimate the amount of 
force applied to match a target force in the self-condition suggesting a deficit in the 
SA mechanisms and therefore in the sense of agency for movement. This suggests 
that malingering is not an explanation for all these patients and instead, they 
display abnormalities in the mechanisms implicated in the experience of oneself as 
the agent controlling one's own movements. 
However, when interpreting these results it is important to highlight three 
important aspects regarding the methodology used: 
First, although SA is a well-recognised phenomenon, the underlying mechanisms 
and its link with the sense of agency is not well understood. Studies using functional 
neuroimaging have shown differences in brain activity during self-generated 
relative to externally generated tactile stimulation in healthy controls: an increase 
in activity of the secondary somatosensory cortex and the anterior cingulate gyrus 
when subjects experienced an externally produced tactile stimulus relative to a self-
produced tactile stimulus has been found. Also, the right anterior cerebellar cortex 
was selectively deactivated by self-produced movement resulting in a tactile 
stimulus and was activated by externally produced tactile stimulation. Patients with 
schizophrenia, in contrast, do not demonstrate attenuation in somatosensory 
cortical activation in association with self-generated movement. This may provide a 
cerebral basis for the increasing body of behavioural evidence that suggests that 
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misjudgement of agency leads to a set of symptoms of schizophrenia such as 
delusions of control, but the evidence is largely indirect.  
Second, I have assessed for the first time with this paradigm a clinical population 
different to patients with schizophrenia and delusions. Therefore data for 
comparing with other patients, especially those with other involuntary movements, 
and interpreting my results is lacking.  
Third, patients with FMD commonly display emotional disturbances and so far little 
is known about how different components of emotions may determine agency 
processing at different stages.  
Therefore, further studies comparing patients with FMD, patients with other 
movement disorders and a group of patients with affective disorders are 
encouraged. In this regard, additional work assessing SA with other non-
behavioural paradigms would be also important. They could study for instance the 
physiological phenomenon of SEPs at the onset of self-generated movements as 
this has been proposed to be the plausible electrophysiological correlate of the 
psychophysiological reduction in intensity of self-generated stimuli probed by the 
force matching and other behavioural paradigms of SA.  
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A new model for functional symptoms 
Taking all the elements emerging from this thesis and summarised in this chapter, it 
seems reasonable to suggest that any model seeking to explain FMD and by 
extension, other functional neurological disorders, must be able to clarify how a 
physical neurological symptom is adopted by an “a priori” normal neurological 
system and also explain the paradox of a symptom that requires attention to 
clinically manifest (which one can argue that it should be associated with a strong 
sense of “voluntariness” ) and that, by contrast, it is felt as involuntary.   
There is a contemporary theory, which is based on active inference and a 
hierarchical Bayesian formulation of the brain, that could accommodate all findings 
described in this thesis (Friston, 2010). There is a robust mathematical framework 
that underpins this theory, which can explain the brain from a cellular to a more 
behavioural perspective. However, in what follows, I will try to summarize the main 
concepts of this theory in a more qualitative, non-mathematical manner. 
Within this theory the brain is understood as an inference machine. Here, 
perception arises from the interaction of the internal model of the world 
(predictions/expectations/beliefs that the brain has about the world) and the 
sensory data that the brain receives from the environment. Any mismatch between 
the expectations/beliefs and the real sensory data from the environment is known 
as prediction error. The aim of the brain is to minimise this mismatch through 
interactions between multiple levels of the cortical hierarchy of the neuronal 
system. The critical issue with this system is that it is possible to “weight” sensory 
data and predictions about that data differently, so one may have more or less 
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influence on the other. Imagine navigating from your bed to the door to the 
bedroom in the dark. If it is your own bedroom which you know well, you are likely 
to “trust” (i.e. weight) your predictions about the structure of the room over any 
sensory information, and so walk boldly (and hopefully correctly) towards the door. 
If it is an unfamiliar room you are more likely to weight your sensory feedback, and 
so feel carefully along the wall with your hand to try to find the door. Here 
attention plays an important role. ‘Attended’ expectations/beliefs or sensations are 
granted high weight or precision and perception (and movement control) is 
adjusted accordingly. 
Within this framework, it can be suggested that sensory data, for instance that 
arising from physical events prior to the onset of FMD, combined with many other 
factors, including panic or affective and cognitive biases, are afforded excessive 
precision (weight) and may lead to the formation of abnormal expectations/beliefs 
trying to explain or predict those sensations. This abnormal expectation/belief 
whose content would be an abnormal movement or sensation may be rendered 
resistant to extinction through the unusually high levels of precision enjoyed during 
its formation. 
When combined with self-directed attention, precision of these expectations are 
high enough to overwhelm contrary sensory data from lower levels and 
automatically produce the abnormal movement consistent with the content of the 
expectation. This would fit with my results suggesting that the motor impairment 
occurs when conscious attentive control of movement is possible or when attention 
is directed to the symptom.  
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It is not clear at present exactly how one can place the phenomenon of SA within 
this framework, and therefore how one can explain the way in which SA, sense of 
agency and this Bayesian model of the brain all interact. One suggestion is that 
abnormal attention towards the body in patients with FMD may itself disrupt SA 
(Brown et al., 2013). If SA is part of the mechanism whereby a movement is 
signalled as intended/willed or not, then its disruption by abnormal attention 
towards the body in FMD may be in part a mechanism for why patients might be 
more likely to lose a sense of agency for their actions (it is of note that a proportion 
of patients with FMD develop progression and spread of symptoms over time with 
no particular trigger).  
This conclusion raises two crucial questions. First, is the loss of SA in FMD patients a 
‘trait’: is it present before and after their motor symptoms? Second, what further 
factors are required to transform a trait loss of SA into a state loss of agency for a 
particular action? Hopefully, further work will help to provide answers.  
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9.1 Conclusions 
FMD and functional neurological symptoms in general are common and disabling 
and represent one of the most enigmatic disorders of the brain. Surprisingly, we are 
still in the infancy of understanding the underlying pathophysiological mechanism. 
The finding of the studies described in this thesis may go some way to enlightening 
us on how these symptoms are generated and why they may feel involuntary. 
Although these studies may be interpreted as snapshots of what may be occurring 
in this group of patients, they do not, unfortunately, provide a clear explanation for 
why these perplexing symptoms occur. It was Sigmund Freud himself who 
recognized “if by doing this research we have taken a step forward along the path 
first traced so successfully by Charcot with his explanation of hysteria, we cannot 
conceal from ourselves that this has brought nearer to an understanding only of the 
mechanism of hysterical symptoms and not of the internal causes of hysteria. We 
have done no more than touch upon the aetiology of hysteria” (Breuer and Freud, 
1974).  
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9.2 Implications for further research 
As I mentioned at the very beginning of this thesis, I have assessed different aspects 
of the pathophysiology of FMD in each of the studies included. In this last chapter I 
have gone through each of them and I have suggested further work to improve 
them from a methodological perspective. One step forward would be to look at 
them before and after recovery from symptoms. This could help to identify whether 
they are actually important in symptom generation or not. 
For instance, if I was asked to start more studies on FMD, I would assess SA in 
patients before and after recovery. In this way, I could better interpret whether 
reduced SA is a trait which makes one vulnerable to developing FMD or it is a state 
that is only present when patients are symptomatic. This work would be important 
to be more confident about the underlying mechanisms of this condition and also 
to develop biomarkers which could then be used as surrogate markers in clinical 
trials or perhaps even as predictive markers of likely treatment response or poor 
prognosis.  
Finally, new areas to explore in the future would be to demonstrate whether other 
functional neurological symptoms share common underlying mechanisms of 
symptom production. I have only assessed patients with FMD in my work and 
generalizability of my results to other functional patient samples is not possible. An 
interesting aspect would be to demonstrate that abnormally focussed attention is 
also present, for instance, in the generation of symptoms characterised by loss of 
function such as weakness and hypoesthesia. From the clinical point of view it is 
often possible to demonstrate that functional paresis may improve with distraction 
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but demonstration that functional anaesthesia may depend on the presence of 
attention is more difficult. This is because attention is unavoidably directed to the 
symptom when one assesses sensation. In this regard, further studies could 
combine functional imaging and evoked potentials to explore different attentional 
responses when manipulating attention towards/away the symptoms in patients 
with functional sensory loss.  
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